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The simultaneous control of diastereoselectivity and regioselectivity in Zn-
catalyzed allenylation reactions of N-protected L-α-amino aldehydes is reported. A 
reversal in diastereoselectivity could be realized by variation of the ɑ-amino aldehyde 
protecting groups. A range of 1-allenyl-2-amino alcohols were obtained with 
excellent regioselectivity and converted to oxazolidinones and dihydrofurans. Many 
of which could be isolated as single diastereoisomers and without significant erosion 
of ee, making this a practical catalytic synthesis of highly functionalized heterocycles. 
 
Introduction 
Allenyl and propargyl boronates have emerged as key reagents for catalyzed 
allenylation and propargylation reactions of carbonyls and imines, providing rapid 
synthesis of allenes and alkynes with pendant heteroatoms via C–C bond formation.1 
Allenes are valuable intermediates for target-oriented synthesis and methodology 
development because they can undergo a vast array of transformations and have high 
levels of structural diversity.1e Allenes bearing pendant heteroatoms, such as N or O, 
are particularly important due to the ability of these heteroatoms to engage in 
cyclization reactions with the reactive allene moiety – typically under the catalysis of 
π-philic transition metals.2 Furthermore, a number of natural products and 
 2 
pharmaceuticals feature allenes with pendant heteroatoms.3 
A powerful route to allenes with a pendant O has been developed by Fandrick 
et al. who have demonstrated that Et2Zn catalyzes the regioselective allenylation of 
various achiral aldehydes and ketones with allenylboronic acid pinacol ester 1 
(Scheme 1a).4a This seminal study indicated that this was a kinetically controlled 
process, where addition of a catalytically generated propargyl zinc intermediate to the 
carbonyl electrophile competes with equilibration of the propargyl and allenyl 
intermediates. They also demonstrated that a regiochemical switch to the more typical 
homopropargyl alcohols was possible when the reaction was run at room temperature 
and under thermodynamic control.4b More recently, Kobayashi showed that a 
Zn(HMDS)2-catalyst process with allenylboronic acid 2,2-dimethyl-1,3-propanediol 
ester 1ʹ could also give either the allenyl or homopropargyl alcohols from the same 
starting materials by using kinetic or thermodynamic reaction control, respectively 
(Scheme 1a).5 Despite these reports, methods to prepare allenes with multiple pendant 
heteroatoms are extremely rare6 and mostly limited to systems containing only 
oxygen, rather than both O and N; furthermore, the methods that do exist are not 
catalytic.7 Combining both O and N reactive elements in a single allenic substrate 
would allow the synthesis of highly functionalized heterocycles with multiple 
heteroatoms. However, the potential route to these compounds via catalytic 
allenylation of α-amino aldehydes8 (A, Scheme 1b) has not been developed; although 
the preparation of propargyl amino alcohols by the stoichiometric addition of 
propargylzinc species to α-amino aldehydes has been established.9 Such a method 
would be challenging due to the requirement for concurrent control of both 
regioselectivity and diastereoselectivity – something that has not been achieved to 
date. Herein, we report a simultaneous control of diastereoselectivity and 
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regioselectivity in the Et2Zn-catalyzed allenylation reactions of chiral α-amino 
aldehydes with allenylboronic acid pinacol ester 1. 
 
Scheme 1. (a) Previous methods for the preparing allenylcarbinols from 




The resulting allenic products are direct precursors to 2,5-dihydrofurans with a 
pendant N (25, Scheme 1b) and allenyloxazolidinones (23, Scheme 1b), which are 
two key heterocycles in a diverse array of biologically active structures, fragrance 
compounds, antirheumatics and antidiabetics.10,11 Diastereoselective methods to 
prepare oxazolidinones with pendant unsaturated moieties are severely limited,12 and 
while the preparation of 2,5-dihydrofurans by Au-catalyzed cyclisation of allenes is 
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well known, the same method to 2,5-dihydrofurans with pendant N are unknown – the 
only other routes involve long non-general multi-step synthesis.13 
 
Results and Discussion 
The L-alanine-derived N-Boc protected α-amino aldehyde 2a8 was first chosen 
for investigation of these reactions using diethylzinc as a catalyst under the reaction 
conditions shown in Table 1. We chose to focus on diethylzinc as it is a commercially 
available and mild reagent unlikely to cause racemization of the α-amino aldehyde 
starting materials.  When the reaction of allenyl boronate 1 and the aldehyde 2a was 
conducted in toluene in the absence of Et2Zn (entry 1), a slow background reaction 
was observed to give only propargyl amino alcohol 16a, in low yield and with low 
diastereoselectivity. The addition of 5 mol% of the Et2Zn catalyst resulted in a more 
rapid reaction to give the allene 9a with almost complete control of allenyl to 
propargyl regioselectivity, but with modest syn diastereoselectivity (entry 2). 
Switching to the more polar solvent THF resulted in the reversal of regioselectivity to 
favour the propargyl product 16a, but with almost no diastereoselectivity (entry 3). 
The reaction also proceeded in CH2Cl2 but with modest regioselectivity (entry 4). An 
increase in the amount of catalyst from 5 mol% to 10 mol% in toluene improved the 
yield significantly from 77% (entry 2) to 92% (entry 5), with moderate 
diastereoselectivity. In an attempt to improve the diastereoselectivity, the reaction was 
conducted at −40 °C (entry 6), but no reaction was observed.  
At this point alternate protecting groups on the nitrogen were investigated in 
an attempt to further control the diastereoselectivity. The N-Ts and N-Fmoc alanals 3 
and 4 (entries 7 and 8) did not undergo the desired allenylation/propargylation 
reaction, while N-Tr alanal 5 (entry 9) provided the corresponding 1-allenyl-2-amino 
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alcohol in high yield and regioselectivity – however, the diastereoselectivity was 
poor. After testing a range of singly N-protected α-amino alanals, N,N-diprotected α-
amino alanals were investigated to see if a switch in diastereoselectivity was possible 
by virtue of increased steric bulk at the nitrogen of these substrates (entries 10-12).14 
The reaction of the N-Bn, N-Boc alanal 6a proved the most rewarding giving the 
allenyl product 13 with good regioselectivity (89:11) and high diastereoselectivity (dr 
=19:1 anti:syn). 














aReaction conditions: 1 (1.10 equiv.), Et2Zn, solvent, 0 
oC, 18 h. 
bIsolated yield of allene and propargyl products. 
cRegioselectivity of determined by 1H NMR analysis of the 
crude reaction product – stereochemistry of propargyl products 
not determined. dThe reaction was carried out at -40 oC. 
eDecomposition of SM. fRecovery of SM. g1.3 equiv. of 1 was 
used. hDetermined by 1H NMR analysis of N-Boc deprotected 
crude RM. Lowering of the catalyst loading for this substrate 
resulted in incomplete conversion. iIsolated yield for the major 
allene diastereoisomer.  
 
The anti and syn configurations assigned to 9a and 13a, respectively, were 
based on 1H NMR analysis, including the nOe interactions between H4, H5 and the 
CH3 group in the corresponding oxazolidinones 23a and 24 (Scheme 2) and the 
 







1 NHBoc PhMe 0 12 (0:100) 2.6:1 
2 NHBoc PhMe 5 77 (97:3) 2.6:1 
3 NHBoc THF 5 60 (5:95) 1.1:1 
4 NHBoc CH2Cl2 5 38 (71:29) 2:1 
5 NHBoc PhMe 10 92 (93:7) 2.6:1 
6 NHBocd PhMe 10 0 0 
7 NHTs PhMe 10 0e 0 
8 NHFmoc PhMe 10 0f 0 
9 NHTr PhMe 10 82 (84:16) 1.3:1 
10 NBnBocg PhMe 10 96 (89:11) 1:19h 
11 NBnTsg PhMe 10 54i (94:6) 1:1.5 
12 NBn2
g PhMe 10 50i (94:6) 1:1.3 
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magnitudes of J4,5 couplings (J4,5 = 6.0 Hz for 23a and J4,5 = 7.2 Hz for 24) which 
were also consistent with these assignments.6a It is proposed that the syn 
diastereoisomer is likely formed via a Cram−chelate-like model, where interaction 
between the aldehyde and the N-H drives the direction of nucleophilic attack. 
(Scheme 2a).14e,f Conversely, switching to the aldehyde having a more steric bulky, 
doubly protected, nitrogen favors Felkin−Ahn control as H-bonding is no longer 
possible (Scheme 2b).14a-d That the dr for the uncatalyzed reaction (Table 1, entry 1) is 
identical to the catalyzed provides further support for this H-bond model, rather than 
Zn playing a role in chelation. 
Scheme 2. Determination of relative configuration of the allenyl products.  
 
 
While only a moderate diastereoselectivity was observed for the allenylation of N-Boc 
protected α-amino aldehyde 2a, the reactions are highly regioselective. Furthermore, 
the levels of diastereoselectivity observed in Table 2 are comparable to the recently 
reported cross-benzoin condensation using N-Boc protected α-amino aldehydes.14d,e 
We found that base-induced conversion to the allenyl oxazolidinones 23 provides a 
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convenient method for producing regio- and diastereomerically enriched products (up 
to >98:2 for the majority of cases) after chromatographic purification for the removal 











































aReaction conditions: (i) 1 (1.1 equiv.), Et2Zn (10 mol%), 
toluene, 0 oC, 18 h; (ii) NaH (2 equiv.), THF, r.t, 1.5 h. 
bIsolated yield, with dr measured on purified oxazolidinone 
after chromatographic purification. cRegioselectivity and dr 
estimated by 1H NMR analysis of purified 9. dIsolated yield of 
the single major diastereomer. eee was determined by 1H NMR 
analysis of the resulting diastereomeric (S)-
Table 2. Reaction scope of 5-allenyl 
oxazolidinonesa  
 








camphorsulfonamide derivatives (see SI). 
 
 These structures are more convenient building blocks than the precursor N-
protected amino-alcohols as their NMR spectra are more clearly defined due to the 
absence of rotamers and they have a rigid stereodefined oxazolidinone unit combined 
with a reactive allene moiety. This is the first example of oxazolidinones bearing a 
reactive C5 allenyl side chain along with the free NH,15 which suggests they should be 
powerful synthetic intermediates for the synthesis of biological active compounds. 
Therefore, the optimized reaction conditions for the Zn-catalyzed allenylation 
reactions were performed for other chiral N-Boc α-amino aldehydes having different 
aryl and aliphatic side chains, before conversion to the corresponding allenyl 
oxazolidinone (Table 2). These reactions afforded the syn 1-allenyl-2-amino alcohols 
9a-9f with high regioselectivities and generally provided high yields (70-92%) and 
moderate to high diastereoselectivities (2.3:1−9:1 syn/anti). For the aliphatic R 
substituents, the dr improved as the size of the R group of 2 increased from Me (2a) 
to i-Pr (2d). The 1-allenyl-2-amino alcohol products underwent base-induced 
cyclisations to give 5-allenyloxazolidinones 23a-23f which could be isolated in yields 
of 50-74% – in the majority of cases (23a-c and 23f) these were obtained as single 
diastereomers, after separation of the major diasteromer using column 
chromatography, thus providing practical access to these intriguing heterocycles.12,15  
We next explored the substrate scope of the allenylation reaction of the N-Bn, 
N-Boc aldehydes 6. The NMR spectra for the direct allenylation products are 
complicated by the presence of a mixture of rotamers, diastereoisomers and 
regioisomers, therefore dihydrofurans 25 were targeted as the final desired products.16 
Consequently, following allenylation of aldehydes 6a-g under the optimized 
conditions, a sequential Au(I)-catalyzed cyclization17 and N-Boc deprotection was 
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carried out on the crude reaction mixture to give dihydrofurans 25 in good three-step 
yields (Table 3). In three cases, the products (25a, 25d and 25f) could be obtained as 
single diastereoisomers after purification by column chromatography and the others in 
good to modest dr. The dr as estimated by the 1H NMR of the crude dihydrofurans 
(25) is essentially the same as the purified material, expect for 25f, which showed a dr 
of 4.9:1 in the crude reaction mixture, indicating the minor diastereomer had been 
removed during purification. This method is advantageous for two reasons, firstly the 
dihydrofurans are medicinally important skeletons and secondly, the direct N-Boc 
deprotection of allene products 13 resulted in formation of an unstable product.18 
Despite the importance of these structures, we are unaware of any general methods to 
prepare 2,5-dihydrofurans with a pendant nitrogen atom – let alone in a stereodefined 
fashion. The N-Boc protected proline-derived amino aldehyde 6g performed well in 
the reaction to give 13g, and then the corresponding cyclized material 25g. The 









































aReaction conditions: (i) 1 (1.3 equiv.), Et2Zn (10 mol%), PhMe, 0 
oC, 18 h; (ii) AuPPh3NTf2 (10 mol%), DCE, 60 
oC, 8 h; (iii) 
TMSCl (5 equiv.), MeOH, r.t, overnight. bIsolated yields over 
three steps without any intermediate purification. cdr determined 
by 1H NMR analysis of purified 25. dThe N-Boc deprotected 
product could not be obtained due to instability. eIsolated yield 
from two steps. 
 
All the α-amino aldehydes utilized in this study were enantiomerically 
enriched and obtained from naturally occurring L-α-amino acids and are generally 
known for their propensity to racemization.8 Therefore, the enantioretention of 
representative reactions from Tables 2 and Table 3 were investigated and gratifyingly, 
no erosion of enantiopurity was observed in any case. The ees of diastereomerically 
enriched oxazolidinones 23a-c and 23f were determined by preparation of their (S)-
camphorsulfonyl derivatives according to the previously reported method20 (see SI). 
The ees of 23a (ee 96%) and 23c (ee 86%) were identical to those of their precursor 
aldehydes 2a (ee 96%)8 and 2c (ee 86%), which indicates little or no erosion of the 










enantiomeric purities of the aldehydes during the reaction steps (aldehyde ee from 
chiral HPLC analysis of the corresponding alcohol, see SI). However, this method 
was not suitable for the 2,5-dihydrofuran products 25 due to instability of the 
corresponding camphorsulfonyl derivative. Therefore, the ee of the precursor 
aldehyde 6a (ee 91%) was determined by chiral HPLC (see SI), which was identical 
to that of its derived dihydrofuran 25a (ee 91%, from chiral HPLC analysis, see SI).    
The proposed mechanism for these allenylation reactions is shown in Scheme 
3 and is consistent with the proposal of Fandrick and co-workers.4 Transmetallation 
between 1 and Et2Zn gives the reactive propargylic Zn species B, which under the 
kinetic control conditions of the reaction reacts in an SE2ʹ fashion with the α-amino 
aldehyde under Felkin−Ahn or Cram−chelation-like control to give Zn alkoxide C. 
The reaction remains catalytic in Zn as the alkoxide can undergo B-to-Zn exchange 
with 1 to regenerate the propargyl zinc species B.  
 






It is also possible that Et2Zn is regenerated by reaction of the alkoxide C with 
EtBpin generated in the initial transmetallation. Isomerisation of propargylic Zn 
species B to the thermodynamically more stable allene species D under our reaction 
conditions is clearly facilitated by more polar solvents, such as THF (entry 3 of Table 
1). 
In conclusion, we have developed the first examples of simultaneous control 
of diastereoselectivity and regioselectivity in Zn-catalyzed allenylation reactions of N-
protected L-α-amino aldehydes. These reactions proceed with high regiochemical 
control to favor the allenic products. Felkin−Ahn control is observed in the presence 
of sterically hindered groups on nitrogen, while Cram−chelation like control is 
observed for singly protected α-amino aldehydes. Furthermore, the products of these 
allenylation reactions undergo intramolecular cyclization to obtain novel 5-allenyl 
oxazolidinones and 2,5-dihydrofurans. Many of these heterocyclic compounds could 
be obtained as single diastereomers in high ee after simple column chromatography, 
making this a practical method for preparing these highly functionalized and useful 




General Methods. Commercial reagents were purchased and used as received 
without any purification. Dry reaction solvents were passed through activated alumina 
columns to obtain dryness before being stored under nitrogen over 4Å molecular 
sieves. All reactions using air/moisture sensitive reagents were performed in oven-
dried glassware, under an atmosphere of nitrogen quipped with a stir bar. Reactions 
were monitored by thin-layer chromatography (TLC) on aluminum backed silica gel 
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sheets, visualizing with UV-light (254 nm) fluorescence quenching, followed by 
staining of the plates with potassium permanganate stain. Column chromatography 
used for compound purification was performed using pre-packed flash grade silica gel 
(40-75 nm) as the stationary phase. 1H NMR and 13C{1H} NMR spectra were 
recorded either at 300, 400 and 500 MHz 1H NMR or at 75, 100 and 125 MHz 13C 
NMR. All 1H NMR and 13C{1H} NMR were recorded in deuterated chloroform 
(CDCl3) containing 0.1% (v/v) tetramethylsilane (TMS). Abbreviations used in the 
description of resonances are: singlet (s), doublet (d), triplet (t), quartet (q), doublet of 
doublets (dd), broad (br) and multiplet (m). All coupling constants (J) were measured 
in hertz (Hz). NMR chemical shift abbreviations were reported in parts per millions 
(ppm) from tetramethylsilane (TMS) and were corrected to 0.00 ppm (TMS) for 1H 
NMR and 77.00 ppm (CDCl3 centre line) for 
13C NMR. The α-amino amino methyl 
ester hydrochlorides were prepared from commercially available amino acids using 
previously reported literature procedures (citations to these compounds are provided 
in the experimental below). 
 
Synthesis of singly N-protected-amino Aldehydes  
The N-protected α-amino aldehydes 2a,21a 2c,21b 2d,21c 2e,21d 321e, 421f and 521g are 
known and were prepared by the previously reported methods. 
 
Methyl (S)-tert-butyl(1-oxopentan-2-yl)carbamate (2b).  
Methyl 2-((tert-butoxycarbonyl)amino)pentanoate S1. To a solution of methyl 
2-aminopentanoate hydrochloride22a (1.00 g, 5.96 mmol) in dry dichloromethane (15 
mL) at 0 °C, was added triethylamine ((0.94 mL, 6.55 mmol, 1.1 equiv.), followed by 
di-tert-butyl dicarbonate (1.56 g, 7.16 mmol, 1.2 equiv.). Stirring was continued for 1 
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h at 0 °C, and then overnight at room temperature. The reaction mixture was then 
quenched by the addition of saturated aqueous NaHCO3(aq) solution and the separated 
organic layer washed with brine solution and dried over Na2SO4. Purification by flash 
column chromatography (EtOAc/hexane 3:7) yielded methyl 2-((tert-
butoxycarbonyl)amino)pentanoate S1 as a colorless oil (1.29 g, 93% yield). 1H NMR 
matched that reported previously, but other characterization data has not been 
published so is included here.23 Rf (Et2O/hexane 2:8) = 0.42. 





H} NMR (125 MHz, CDCl3) δ 13.5, 18.5, 28.1, 34.6, 52.0, 53.1, 79.5, 
155.3, 173.4. IR (νmax/cm
-1) 3370 (w), 2963 (m), 2934 (m), 1743 (s), 1713 (s), 1507 
(s), 1365 (s), 1249 (s), 1159 (s), 1011 (m), 779 (m). HRMS (ESI-TOF) m/z calcd for 
C11H21NO4Na [M + Na]
+ 254.1368, found 254.1361.  
Methyl (S)-tert-butyl(1-oxopentan-2-yl)carbamate (2b). To a solution of 
methyl 2-((tert-butoxycarbonyl)amino)pentanoate S1 (0.19 g, 0.82 mmol) in dry 
toluene (2 mL) at −78 °C, was added dropwise diisobutylaluminum hydride (5.5 M in 
n-hexane, 0.30 mL, 1.64 mmol, 2 equiv.) over a period of 45 min. The mixture was 
stirred at the same temperature for 1.5 h, and then quenched by the addition of 
precooled methanol. The reaction mixture was allowed to warm to room temperature, 
ice (1 g) was added with heavy agitation, the mixture filtered and the filtrate was 
extracted with chloroform. The organic layer was washed with brine solution, dried 
over Na2SO4 and concentrated under reduced pressure to 2b as a colorless oil which 




1-carboxylate (2f).  
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tert-Butyl 3-(2-((tert-butoxycarbonyl)amino)-3-methoxy-3-oxopropyl)-1H-
indole-1-carboxylate S2. Triethylamine (0.56 mL, 3.92 mmol, 1.0 equiv.) was added 
dropwise to a stirred solution of methyl tryptophanate hydrochloride22b (1.00 g, 3.92 
mmol) in THF (15 mL) at 0 oC. Then, di-tert-butyl dicarbonate (1.71 g, 7.85 mmol, 
2.0 equiv.) and 4-(dimethylamino)pyridine (0.72 g, 5.88 mmol, 1.5 equiv.) were 
added and the mixture was stirred overnight at room temperature. The reaction 
mixture was concentrated under reduced pressure, and the tert-butyl 3-(2-((tert-
butoxycarbonyl)amino)-3-methoxy-3-oxopropyl)-1H-indole-1-carboxylate S2 was 
obtained after flash column chromatography (EtOAc/hexane 3:7). Colorless oil (1.59 
g, 97%). The data recorded matched that previously reported.25  
(S)-tert-Butyl 3-(2-((tert-butoxycarbonyl)amino)-3-oxopropyl)-1H-indole-1-
carboxylate (2f). The title compound 2f was obtained following the same procedure 
used for 2b with tert-butyl 3-(2-((tert-butoxycarbonyl)amino)-3-methoxy-3-
oxopropyl)-1H-indole-1-carboxylate S2 (0.11 g, 0.26 mmol) and diisobutylaluminum 
hydride (5.7 M in n-hexane, 0.10 mL, 0.57 mmol, 2.2 equiv.) in toluene (1 mL). 
Colorless gummy oil (0.064 g, 99% yield). 
	= +53.5 (c 3.2 CHCl3). 
1
H NMR 
(500 MHz, CDCl3) δ 1.44 (s, 9H, C(CH3)3), 1.66 (s, 9H, C(CH3)3), 3.22 (br s, 2H, 
CH2Ph), 4.48 (br s, 1H, CH), 5.22 (br s, 1H, NH), 7.25 (br s, 1H, CHAr), 7.32 (br s, 
1H, CHAr), 7.43 (br s, 1H, CHAr), 7.54 (br s, 1H, CHAr), 8.13 (br s, 1H, CHAr), 9.65 (s, 
1H, CHO). 13C{1H} NMR (125 MHz, CDCl3) δ 25.0, 28.2, 28.3, 59.6, 80.2, 83.8, 
114.8, 115.3, 119.0, 122.7, 124.2, 124.7, 130.2, 135.5, 149.5, 155.4, 199.5. IR 
(νmax/cm
-1) 3371 (w), 2979 (m), 2361 (w), 1730 (s), 1700 (s), 1507 (s), 1452 (s), 1367 
(s), 1253 (s), 1154 (s), 1086 (s), 856 (m), 766 (s), 744 (s). HRMS (ESI-TOF) m/z 
calcd for C21H28N2O5Na [M + Na]
+ 411.1896, found 411.1878. 
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Preparation of doubly protected α-amino esters and aldehydes 
The N-Bn,N-Boc α-amino aldehyde 6e26 and the N-Boc α-amino prolinal 6g27, 
N-Bn,N-Ts α-amino alaninal 728 and N,N-dibenzyl-α-amino alaninal 829 are known 
and were prepared by the previously reported methods. The remaining N-Bn,N-Boc α-
amino aldehydes were prepared as described below. The starting materials methyl 
tosyl-L-alaninate21e, (S)-tert-butyl benzyl(1-hydroxypropan-2-yl)carbamate30a, (S)-
methyl N-benzyl valinate 31a and (S)-2-(benzylamino)-3-methylbutan-1-ol31b were 
prepared as previously described. 
 
 
tert-Butyl benzyl(1-oxopropan-2-yl)carbamate 6a.  
To a stirred solution of tert-butyl benzyl(1-hydroxypropan-2-yl)carbamate30a (0.42 g, 
1.58 mmol) in CH2Cl2 (30 mL) at 0 °C, was added saturated aqueous NaHCO3 
solution (15 mL), KBr (0.18 g, 1.58 mmol, 1.0 equiv.) and TEMPO (12.35 mg, 0.079 
mmol, 0.05 equiv.). NaOCl (3.79 mL, 1.89 mmol, 1.2 equiv.) was then added with a 
syringe pump over 30 min. The reaction was stirred for another 15 min at 0 °C. Then, 
the reaction mixture was quenched with saturated aqueous Na2S2O3 solution (15 mL) 
and extracted into CH2Cl2 (3×10 mL). The combined organic layers were dried 
(Na2SO4) and concentrated under reduced pressure to afford the aldehyde 6a, which 
was utilized for the next step without purification. Colorless oil (0.38 g, 91%). The ee 
was determined by chiral HPLC analysis of the corresponding alcohol (obtained by 
NaBH4 reduction of a small quantity of the unpurified aldehyde) using a Phenomenex 
Lux i-Cellulose-5 column; hexane/isopropanol (95:5); flow rate = 0.5 mL/min; 210 




(S)-tert-Butyl benzyl(1-oxopentan-2-yl)carbamate (6b).  
Methyl 2-(benzylamino)pentanoate S3. To a stirred suspension of L-norvaline 
methyl ester hydrochloride22a (1.30 g, 7.75 mmol) and benzyl bromide (0.90 mL, 7.75 
mmol, 1.0 equiv.) in acetonitrile (20 mL), was added potassium carbonate (2.14 g, 
15.50 mmol, 2.0 equiv.) and the mixture was stirred overnight at room temperature. 
The reaction mixture was washed with saturated aqueous NH4Cl solution (30 mL) and 
water (30 mL), dried (MgSO4), concentrated under reduced pressure and purified by 
flash column chromatography (Et2O/hexane 1:9) to obtain the N-benzylated product 
S3. Colorless oil (1.25 g, 73%). Rf (Et2O/hexane 1:9) = 0.16. 
	= −35.4 (c 5.5 
CHCl3). 
1
H NMR (300 MHz, CDCl3) δ 0.88 (t, 3H, J = 7.2 Hz, CH3), 1.33-1.43 (m, 
2H, CH2), 1.57-1.64 (m, 2H, CH2), 1.79 (s, 1H, NH), 3.26 (t, 1H, J = 6.6 Hz, CH), 
3.61 (d, 1H, J = 13.2 Hz, CHPh), 3.67 (s, 3H, CH3), 3.80 (d, 1H, J = 12.9 Hz, CHPh), 




H} NMR (125 MHz, CDCl3) δ 13.8, 19.0, 35.7, 51.5, 
52.1, 60.5, 126.9, 128.2, 128.3, 139.9, 176.0. IR (νmax/cm
-1) 3735 (m), 3031 (w), 2957 
(m), 1734 (s), 1456 (m), 1339 (m), 1267 (m), 976 (m), 732 (m), 698 (s). HRMS (ESI-
TOF) m/z calcd for C13H20NO2 [M + H]
+ 222.1494, found 222.1492.  
Methyl 2-(benzyl(tert-butoxycarbonyl)amino)pentanoate S4. Triethylamine 
(2.58 mL, 9.02 mmol, 2.0 equiv.) was added dropwise to a stirred solution of S3 (1.00 
g, 4.51 mmol) and di-tert-butyl dicarbonate (Boc2O, 1.47 g, 6.77 mmol, 1.5 equiv.) in 
dry dichloromethane (10 mL), and the reaction mixture was stirred for 24 h at room 
temperature. The reaction was washed with aqueous solution of HCl (1M) (15 mL), 
dried (Na2SO4), and concentrated under reduced pressure. Purification was carried out 
by flash column chromatography (Et2O/hexane 1:9) to yield the N-Bn,N-Boc α-amino 
ester S6. Colorless oil (0.89 g, 62%). Rf (Et2O/hexane 1:9) = 0.23. 




H NMR (300 MHz, CDCl3) (mixture of rotamers) δ 0.79 (br s, 3H, 
CH3), 1.24 (br s, 2H, CH2), 1.40 (br s, 4.2H, C(CH3)3), 1.45 (br s, 4.8H, C(CH3)3), 
1.62-1.75 (m, 1H, CH), 1.84-1.94 (m, 1H, CH), 3.55 (s, 3H, CH3), 3.90-4.80 (m, 3H, 




H} NMR (75 MHz, CDCl3) (mixture of 
rotamers, minor rotamer indicated by asterisk) δ 13.5, 19.5, 28.1, 31.6, 32.3*, 32.4, 
49.4, 50.7*, 51.5, 58.5, 59.1*, 80.2, 126.8, 127.1, 128.0, 128.3, 138.0, 138.9*, 155.6, 
172.1. IR (νmax/cm
-1) 3031 (w), 2961 (m), 2875 (w), 1739 (s), 1700 (s), 1452 (s), 1319 
(m), 1248 (m), 1163 (m), 979 (m), 862 (m), 734 (m), 699 (s). HRMS (ESI-TOF) m/z 
calcd for C18H27NO4Na [M + Na]
+ 344.1838, found 344.1833. 
tert-Butyl benzyl(1-hydroxypentan-2-yl)carbamate S5. To a solution of lithium 
aluminum hydride (1 M solution in THF, 4.98 mL, 4.98 mmol, 2.0 equiv.) at 0 °C, 
was added dropwise methyl 2-(benzyl(tert-butoxycarbonyl)amino) pentanoate S4 
(0.80 g, 2.49 mmol) in THF (3 mL) and the mixture was stirred at the same 
temperature for 30 min. The reaction was quenched with water (1 mL), filtered, and 
concentrated under reduced pressure. The crude product was purified by flash column 
chromatography (EtOAc/hexane 4:6) to obtain the corresponding α-amino alcohol 
product S5 as a colorless oil (0.60 g, 82%). Rf (EtOAc/hexane 4:6) = 0.61. 
	= 
+16.3 (c 4.6 CHCl3). 
1
H NMR (500 MHz, CDCl3) (mixture of rotamers) δ 0.84 (br s, 
3H, CH3), 1.26 (br s, 2H, CH2), 1.37 (br s, 7H, C(CH3)3, CH), 1.49 (br s, 4H, 
C(CH3)3, CH), 3.40-3.60 (m, 3H), 3.84-3.86 (m, 1H, CH), 4.21-4.70 (m, 2H, CH2Ph), 




H} NMR (125 MHz, CDCl3) (mixture of rotamers, 
minor rotamer indicated by asterisk) δ 13.9, 19.7, 28.3, 30.9, 31.7*, 48.2*, 49.3, 59.2, 
64.1, 80.1, 126.9, 127.6, 128.3, 139.6, 156.9. IR (νmax/cm
-1) 3446 (m), 2959 (m), 2930 
(m), 2873 (m), 1665 (s), 1465 (m), 1410 (s), 1341 (m), 1243 (m), 1166 (s), 1053 (w), 
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701 (s). HRMS (ESI-TOF) m/z calcd for C17H27NO3Na [M + Na]
+ 316.1889, found 
316.1891.   
tert-Butyl benzyl(1-oxopentan-2-yl)carbamate 6b. Swern oxidation of methyl 
tert-butyl benzyl(1-hydroxypentan-2-yl)carbamate S5 (0.59 g, 2.01 mmol) was 
carried out with oxalyl chloride (0.37 mL, 4.02 mmol, 2 equiv.), DMSO (0.61 mL, 
8.04 mmol, 4 equiv.) and Et3N 4.56 mL, 32.17 mmol, 16 equiv.) in CH2Cl2 (5 mL) at 
−78 °C. The reaction mixture was quenched with saturated aqueous NaHCO3 solution 
(5 mL) and extracted into CH2Cl2 (3×3 mL). The combined organic layers were 
washed with brine solution (10 mL), dried (Na2SO4) and concentrated under reduced 
pressure to yield 6b as a colorless oil (0.50 g, 85%), which was used in the 
allenylation reaction without further purification. (Caution! This reaction is carried 
out at −78 °C as it has been reported that oxalyl chloride and dimethyl sulfoxide can 
react explosively at room temperature. Furthermore, this procedure should be carried 
out in a fumehood since a dimethyl sulfide is an odorous by-product of the reaction).32 
Rf (EtOAc/hexane 1:9) = 0.43. 
	= −92.3 (c 7.0 CHCl3). 
1
H NMR (300 MHz, 
CDCl3) (mixture of rotamers) δ 0.89 (t, 3H, J = 7.2 Hz, CH3), 1.34-1.41 (m, 2H, 
CH2), 1.45 (br s, 9H, C(CH3)3), 1.49-1.80 (m, 1H, CH), 1.89-1.99 (m, 1H, CH), 3.45 
(br s, 0.6H, CH), 3.76 (br s, 0.4H, CH), 4.11-4.22 (m, 1H, CHPh), 4.70 (br d, 0.4H, J 
= 15.0 Hz, CHPh), 4.98 (br d, 0.6H, J = 15.0 Hz, CHPh), 7.26-7.35 (m, 5H, 5CHAr), 
9.35 (br s, 0.6H, CHO), 9.44 (br s, 0.4H, CHO). 13C{1H} NMR (75 MHz, CDCl3) 
(mixture of rotamers, minor rotamer indicated by asterisk) δ 13.8, 19.5, 28.1, 29.2*, 
30.4, 51.4*, 51.8, 65.5, 80.9*, 81.3, 127.6, 128.3, 128.6, 137.7, 138.1*, 155.1, 199.5. 
IR (νmax/cm
-1) 2965 (m), 2933 (m), 2876 (w), 1739 (s), 1692 (s), 1452 (s), 1405 (s), 
1365 (s), 1249 (s), 1180 (s), 1002 (m), 864 (m), 735 (s), 699 (s). HRMS (ESI-TOF) 
m/z calcd for C17H25NO3Na [M + Na]
+ 314.1732, found 314.1741. 
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tert-Butyl benzyl(4-methyl-1-oxopentan-2-yl)carbamate (6c) 
 Methyl N-benzyl leucinate S6. To a stirred suspension of L-methyl leucinate 
hydrochloride33 (1.0 g, 5.50 mmol) and benzyl bromide (0.7 mL, 6.05 mmol, 1.1 
equiv.) in acetonitrile (20 mL), was added potassium carbonate (1.52 g, 11 mmol, 2 
equiv.) and the mixture was stirred overnight at room temperature. The reaction 
mixture was washed with saturated aqueous NH4Cl solution (20 mL) and water (20 
mL), dried (MgSO4), concentrated under reduced pressure and purified by flash 
column chromatography (Et2O/hexane 1:9) to obtain the N-benzylated product S6. 
Light yellow oil (0.996 g, 77%). Data matches that reported previously.34 
 Methyl N-benzyl-N-(tert-butoxycarbonyl) leucinate S7. Triethylamine (0.81 
mL, 2.75 mmol, 1.1 equiv.) was added dropwise to a stirred solution of S6 (1.00 g, 
4.51 mmol) and di-tert-butyl dicarbonate (Boc2O, 0.67 g, 3.1 mmol, 1.24 equiv.) in 
dry dichloromethane (5 mL), and the reaction mixture was stirred for 24 h at room 
temperature. The reaction was washed with aqueous solution of HCl (1M) (5 mL), 
dried (Na2SO4), and concentrated under reduced pressure. Purification was carried out 
by flash column chromatography (Et2O/hexane 1:9) to yield the N-Bn,N-Boc α-amino 
ester S7. Colorless oil (0.59 g, 70%). Data matches that previously reported.35 
 tert-Butyl benzyl(4-methyl-1-oxopentan-2-yl)carbamate 6c. To a solution of 
S9 (0.58 g, 1.74 mmol) in dry diethyl ether (3 mL) at −78 °C, was added dropwise 
diisobutylaluminum hydride (5.0 M in n-hexane, 0.70 mL, 3.49 mmol, 2 equiv.) over 
45 min. The mixture was stirred at the same temperature for 1 h, and was quenched 
with methanol (1 mL). The reaction mixture was allowed to warm to room 
temperature, followed by adding water (2 mL). The crude mixture was filtered 
through a sintered glass funnel and the filtrate was washed with brine (20 mL). The 
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organic layer was dried (Na2SO4) and concentrated under reduced pressure to yield 
the desired aldehyde. Colorless oil (0.35 g, 65%). Data matches that previously 
reported.14d 
 
tert-Butyl benzyl(3-methyl-1-oxobutan-2-yl)carbamate (6d)   
 (S)-Methyl N-benzyl-N-(tert-butoxycarbonyl) valinate S8. Triethylamine (3.32 
mL, 11.56 mmol, 2 equiv.) was added dropwise to a stirred solution of (S)-methyl N-
benzyl valinate31a (1.28 g, 5.78 mmol) and di-tert-butyl dicarbonate (Boc2O, 2.14 g, 
9.82 mmol, 1.7 equiv.) in dry dichloromethane (15 mL), and the reaction mixture was 
stirred for 24 h at room temperature. The reaction was washed with aqueous solution 
of HCl (1M) (15 mL), dried (Na2SO4), and concentrated under reduced pressure. 
Purification was carried out by flash column chromatography (Et2O/hexane 1:9) to 
yield the N-Bn,N-Boc α-amino ester S8. Colorless oil (1.18 g, 63%). Data matches 
that previously reported.31b S8 was then converted into (S)-2-(benzylamino)-3-
methylbutan-1-ol as previously reported for use in the next step.31b 
 (S)-tert-Butylbenzyl(3-methyl-1-oxobutan-2-yl)carbamate 6d. Swern oxidation 
of (S)-2-(Benzylamino)-3-methylbutan-1-ol31b (0.73 g, 2.48 mmol) was carried out 
with oxalyl chloride (0.46 mL, 4.96 mmol, 2 equiv.), DMSO (0.75 mL, 9.94 mmol, 4 
equiv.) and Et3N (5.63 mL, 39.68 mmol, 16 equiv.) in CH2Cl2 (5 mL) at −78 °C. The 
reaction mixture was quenched with saturated aqueous NaHCO3 solution (5 mL) and 
extracted into CH2Cl2 (3×3 mL). The combined organic layers were washed with 
brine solution (10 mL), dried (Na2SO4) and concentrated under reduced pressure to 
yield 6d as a colorless oil (0.558 g, 77%), which was used in the allenylation reaction 





Methyl benzyl-L-tryptophanate S9. Methyl tryptophanate hydrochloride22b (3.60 g, 
14.13 mmol) was neutralized into the free base by dissolving in diethyl ether (20 mL) 
followed by treating with saturated aqueous K2CO3 solution (20 mL). The organic 
layer was dried (Na2SO4) and concentrated under reduced pressure to obtain a light 
yellow oil. To a stirred suspension of neutralized tryptophan methyl ester and MgSO4 
(2.70 g) in dichloromethane (40 mL), was added benzaldehyde (1.43 mL, 14.13 
mmol, 1 equiv.) and the mixture was stirred for 5 h at room temperature. The 
resulting imine compound was dissolved in dry methanol (30 mL) and NaBH4 (0.58 g, 
15.54 mmol, 1.1 equiv.) was added slowly at 0 °C. The solvent was evaporated after 1 
h at 0 °C. Then the mixture was washed by NH4OH (5%, 20 mL), extracted by ethyl 
acetate and dried (Na2SO4). Methyl benzyl-L-tryptophanate S9 was obtained after 
flash column chromatography (EtOAc/hexane 2:8) as a colorless gummy oil (3.12 g, 






Triethylamine (2.85 mL, 9.92 mmol, 2 equiv.) was added dropwise to a stirred 
solution of methyl benzyl-L-tryptophanate S10 (1.53 g, 4.96 mmol) and di-tert-butyl 
dicarbonate (1.02 g, 4.71 mmol, 0.95 equiv.) in dry dichloromethane (20 mL), and 
was stirred for 24 h at room temperature. The crude reaction mixture was 
concentrated under reduced pressure. Then title compound S10 was obtained after 
flash column chromatography (EtOAc/hexane 2:8). Colorless gummy oil (1.37 g, 
67%). Data matches that reported previously.22b      
tert-Butyl (S)-3-(2-(benzyl(tert-butoxycarbonyl)amino)-3-methoxy-3-
oxopropyl)-1H-indole-1-carboxylate S11. To a stirred solution of methyl Nα-benzyl-
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Nα-(tert-butoxycarbonyl)-L-tryptophanate S10 (1.07 g, 2.62 mmol) and di-tert-butyl 
dicarbonate (0.85 g, 3.93 mmol, 1.5 equiv.) in dichloromethane (15 mL), was added 
4-(dimethylamino)pyridine (0.063 g, 0.52 mmol, 0.2 equiv.) and the mixture was 
stirred overnight at room temperature. The reaction mixture was diluted with EtOAc 
(10 mL) and washed with water (30 mL) and saturated aqueous NaHCO3 solution (30 
mL) and brine (30 mL). The organic layer was dried (Na2SO4) and the filtrate was 
concentrated under reduced pressure. The title compound S11 was obtained after flash 
column chromatography (EtOAc/hexane 2:9) as a colorless gummy oil (1.15 g, 86%). 
Rf (EtOAc/hexane 2:9) = 0.48. 
	= −67.2 (c 1.0 CHCl3). 
1
H NMR (300 MHz, 
CDCl3) (mixture of rotamers) δ 1.48 (s, 9H, 3CH3), 1.65 (s, 9H, 3CH3), 3.10-3.39 (m, 
2H, CH2), 3.62 (s, 3H, CH3), 4.15-4.39 (m, 3H, CH2, CH), 7.01-7.42 (m, 9H, 9CHAr), 
8.11 (br d, 1H, J = 6.9 Hz, CHAr). 
13
C NMR (75 MHz, CDCl3) (mixture of rotamers, 
minor rotamer indicated by asterisk) δ 24.9*, 25.9, 28.2*, 28.3, 51.8*, 52.0, 59.6, 
59.8*, 80.5*, 80.8, 83.2*, 83.4, 115.2, 115.3*, 116.5, 116.7*, 118.5, 118.7, 118.9*, 
122.4, 124.00*, 124.09, 124.4, 124.3*, 126.9, 127.0, 127.1*, 127.6*, 127.9, 128.1*, 
128.3, 128.5, 130.2*, 130.5, 135.4, 137.2, 137.6*, 149.5, 155.2, 171.4, 174.9*. IR 
(νmax/cm
-1) = 2976 (m), 2931 (m), 2357 (w), 2167 (w), 1732 (s), 1695 (s), 1452 (s), 
1365 (s), 1253 (s), 1155 (s), 1083 (s), 1016 (m), 858 (m), 742 (s), 698 (s). HRMS 
(ESI) m/z calcd for C29H36N2O6Na [M + Na]
+ 531.2471, found 531.2492. 
tert-Butyl (S)-3-(2-(N-benzylformamido)-3-methoxy-3-oxopropyl)-1H-indole-
1-carboxylate 6f. To a solution of tert-butyl 3-(2-(benzyl(tert-
butoxycarbonyl)amino)-3-methoxy-3-oxopropyl)-1H-indole-1-carboxylate S11 (0.55 
g, 1.08 mmol) in diethyl ether (3 mL) at −78 oC, was added dropwise 
diisobutylaluminum hydride (5.4 M in n-hexane, 0.40 mL, 2.16 mmol, 2 equiv.). The 
mixture was stirred at the same temperature for 1 h, and was quenched with methanol 
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(1 mL). The reaction mixture was allowed to warm to room temperature, followed by 
adding water (2 mL). The crude mixture was filtered and the filtrate was washed with 
brine solution (20 mL). The organic layer was dried (Na2SO4) and concentrated under 
reduced pressure to yield the desired aldehyde 6f. Light orange oil (0.398 g, 77%). Rf 
(EtOAc/hexane 2:8) = 0.63. 
	= −113.5 (c 9.8 CHCl3). 
1
H NMR (500 MHz, 
CDCl3) (mixture of rotamers) δ 1.49 (s, 9H, C(CH3)3), 1.67 (s, 9H, C(CH3)3), 3.04-
3.09 (m, 0.5H, CH), 3.29-3.31 (m, 0.5H, CH), 3.37-3.42 (m, 1H, CH), 3.52 (t, 1H, J = 
16.0 Hz, CH), 3.76-3.77 (m, 1H, CHPh), 4.50 (d, 0.5H, J = 15.0 Hz, CHPh), 4.76 (d, 
0.5H, J = 15.0 Hz, CHPh), 7.00 (br s, 2H, 2CHAr), 7.19-7.24 (m, 4H, 4CHAr), 7.31-




H} NMR (125 MHz, CDCl3) (mixture of rotamers, minor rotamer indicated by 
asterisk) δ 22.7, 23.8*, 28.2, 28.3*, 52.0, 52.7*, 65.3, 66.0*, 81.2*, 81.8, 83.5*, 83.6, 
115.4*, 115.5, 116.4, 116.7*, 118.5, 118.7*, 122.64, 122.69*, 124.2*, 124.3*, 124.5, 
124.6, 127.6*, 127.75, 127.78*, 128.4, 128.63, 128.65*, 130.1, 130.4*, 135.6, 137.3, 
137.5*, 149.5, 154.8, 155.3*, 198.6, 199.0*. IR (νmax/cm
-1) 2978 (m), 2814 (w), 2364 
(w), 2163 (w), 1730 (s), 1733 (s), 1683 (s), 1452 (s), 1365 (s), 1308 (m), 1251 (s), 
1154 (s), 1085 (s), 976 (m), 856 (s), 743 (s), 700 (s). HRMS (ESI-TOF) m/z calcd for 
C28H33N2O5 [M − H]
+ 477.2389, found 477.2382. 
 
(S)-Methyl N-benzyl-N-tosyl alaninate S12. The aldehyde 8 was prepared as 
previously reported29 but a modified synthesis of the ester starting material required 
for its synthesis was employed. Potassium carbonate (2.37 g, 17.32 mmol, 2 equiv.) 
was added to a stirred solution of methyl tosyl-L-alaninate21e (2.23 g, 8.66 mmol) and 
benzyl bromide (1.50 mL, 13.00 mmol, 1.5 equiv.) in acetonitrile (30 mL), and was 
stirred overnight at room temperature. The reaction mixture was washed with 
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saturated aqueous NH4Cl solution (50 mL) and water (50 mL), dried (MgSO4), 
concentrated under reduced pressure and purified by flash column chromatography 
(EtOAc/hexane 3:7) to obtain the methyl N-benzyl-N-tosyl-alaninate S13. Colorless 
oil (2.74 g, 88%). Rf (EtOAc/hexane 3:7) = 0.54. 
	= −42.5 (c 2.5 CHCl3). 
1
H 
NMR (500 MHz, CDCl3) δ 1.26-1.28 (m, 3H, CH3), 2.42 (br s, 3H, CH3), 3.42 (br s, 
3H, CH3), 4.42 (br d, 1H, J = 14.5 Hz, CHPh), 4.55 (br d, 1H, J = 16.0 Hz, CHPh), 




H} NMR (125 MHz, CDCl3) δ 16.4, 21.5, 49.1, 52.0, 55.0, 127.4, 127.5, 128.0, 
128.3, 129.5, 137.1, 137.3, 143.4, 171.6. IR (νmax/cm
-1) 2950 (w), 1742 (s), 1456 (m), 
1339 (s), 1152 (s), 1089 (m), 845 (m), 725 (s), 655 (s). HRMS (ESI-TOF) m/z calcd 
for C18H21NO4NaS [M + Na]
+ 370.1089, found 370.1073.    
 
General Procedure A. Allenylation of Chiral N-Boc α-Amino Aldehydes and 
Subsequent Base-Catalyzed Cyclization. To a solution of allenylboronic acid 
pinacol ester 1 (1.1 equiv.) and the amino aldehydes 2a-2f in toluene at 0 °C, was 
added Et2Zn (1 M in toluene, 10 mol%) under nitrogen. The suspension was then 
stirred at 0 °C for 18 h. The reaction mixture was quenched with saturated aqueous 
NH4Cl solution, and washed with saturated aqueous NaHCO3 solution (15 mL) and 
water (10 mL). The organic layer was dried (Na2SO4), concentrated under reduced 
pressure and purified by flash column chromatography (EtOAc/hexane) to afford the 
allenyl amino alcohol products 9a-9f. To a solution of the allenyl product in dry THF 
was added sodium hydride (60% in mineral oil, 2.0 equiv.) at 0 °C and the reaction 
mixture was stirred at room temperature for 90 min. The reaction mixture was 
quenched by saturated aqueous NH4Cl solution, washed with water (10 mL), dried 
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(MgSO4), and then purified by flash column chromatography (acetone/n-pentane) to 
afford the corresponding oxazolidinone products 23a-23f.  
 
tert-Butyl ((2S,3S)-3-hydroxyhexa-4,5-dien-2-yl)carbamate (9a). The title 
compound 9a was obtained after flash column chromatography (EtOAc/hexane 3:7) 
as a 2.6:1 mixture of syn and anti diasteresomers following the general procedure A 
using tert-butyl (1-oxopropan-2-yl)carbamate 2a (0.06 g, 0.34 mmol), allenylboronic 
acid pinacol ester 1 (69.0 µL, 0.37 mmol, 1.1 equiv.) and Et2Zn (1 M in toluene, 35.7 
µL, 0.034 mmol, 10 mol%)  in dry toluene (1 mL). Yellow oil (0.067 g, 92%). Rf 
(EtOAc/hexane 3:7) = 0.36. 1H NMR (500 MHz, CDCl3) (mixture of two allene 
diastereomers, relative integrations given for each diastereomer) δ 1.12 (d, 3H, J = 6.5 
Hz, CH3, minor isomer), 1.19 (d, 3H, J = 7.0 Hz, CH3, major isomer), 1.44 (s, 9H, 
C(CH3)3, for each isomer), 2.87 (br s, 1H, OH, major isomer), 3.17 (br s, 1H, OH, 
minor isomer), 3.71-3.75 (m, 1H, CH, major isomer), 3.75-3.82 (m, 1H, CH, minor 
isomer), 4.09 (br s, 1H, CH, major isomer), 4.23 (br s, 1H, CH, minor isomer),  4.86-




H} NMR (125 MHz, CDCl3) (mixture of two allene diastereomers, minor 
indicated by asterisk) δ 18.8, 19.9, 20.1, 28.3, 29.8, 30.0*, 60.4, 60.8*, 69.3, 69.4*, 
76.8, 79.1, 79.2*, 90.7*, 93.0, 156.6, 156.7*, 207.4, 207.9*. IR (νmax/cm
-1) 3378 (w), 
2976 (w), 1955 (w), 1683 (s), 1506 (m), 1365 (m), 1257 (m), 1162 (s), 1051 (s), 1024 
(s). HRMS (ESI-TOF) m/z calcd for C11H18NO3 [M − H]
+ 212.1287, found 212.1289. 
 
(4S,5S)-4-Methyl-5-(propa-1,2-dien-1-yl)oxazolidin-2-one (23a). The title 
compound 23a was obtained as a single diastereomer following the general procedure 
A using 9a (0.060 g, 0.28 mmol) and sodium hydride (60% in mineral oil, 18.81 mg, 
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0.56 mmol, 2.0 equiv.) in THF (1 mL). Colorless oil (0.024 g, 61%). Rf (2% 
CH2Cl2/Et2O) = 0.52. 
	= −30.3 (c 1.2 CHCl3). 
1
H NMR (500 MHz, CDCl3) δ 
1.28 (d, 3H, J = 6.0 Hz, CH3), 3.75-3.80 (m, 1H, CH), 4.55 (t, 1H, J = 6.5, 7.0 Hz, 
CH), 4.93-5.00 (m, 2H, CH2=C=), 5.32 (q, 1H, J = 7.0 Hz, CH=C=), 6.02 (br s, 1H, 
NH). 13C{1H} NMR (125 MHz, CDCl3) δ 20.0, 54.0, 78.6, 81.6, 89.0, 158.9, 209.2. 
IR (νmax/cm
-1) 3272 (m), 2926 (w), 1955 (w), 1739 (s), 1378 (m), 1003 (s), 942 (s), 
855 (s), 770 (m). HRMS (ESI-TOF) m/z calcd for C7H9NO2Na [M + Na]
+ 162.0531, 
found 162.0537.  
 
tert-Butyl ((4S,5S)-5-hydroxyocta-6,7-dien-4-yl)carbamate (9b). The title 
compound 9b was obtained after flash column chromatography (EtOAc/hexane 2:8) 
as a 5.2:1 mixture of syn and anti diastereomers following the general procedure A 
using tert-butyl(1-oxopentan-2-yl)carbamate 2b (0.149 g, 0.74 mmol), allenylboronic 
acid pinacol ester 1 (155.6 µL, 0.81 mmol, 1.1 equiv.) and Et2Zn (1 M in toluene, 
79.17 µL, 0.074 mmol, 10 mol%)  in dry toluene (2 mL). Colorless oil (0.145 g, 
81%). Rf (EtOAc/hexane 2:8) = 0.45. 
1
H NMR (500 MHz, CDCl3) (mixture of two 
allene diastereomers, relative integrations given for each diastereomer) δ 0.92 (t, 3H, 
J = 7.0 Hz, CH3, for each isomer), 1.31-1.40 (m, 3H, CH and CH2, for each isomer), 
1.43 (s, 9H, C(CH3)3, for each isomer), 1.50-1.56 (m, H, CH, for each isomer), 3.00 
(br s, 1H, OH, minor isomer), 3.17 (br s, 1H, OH, major isomer), 3.59 (br s, 1H, CH, 
major isomer), 3.70-3.73 (m, 1H, CH, minor isomer), 4.16 (br s, 1H, CH, major 
isomer), 4.23 (br s, 1H, CH, minor isomer), 4.85-4.90 (m, 2H, CH2=C=, major 
isomer), 4.94-4.96 (m, 2H, CH2=C=, minor isomer), 5.18-5.27 (m, 1H, CH=C=, for 
each isomer). 13C{1H} NMR (125 MHz, CDCl3) (mixture of two allene 
diastereomers, minor indicated by asterisk) δ 13.9, 19.3, 28.3, 34.0, 34.2*, 54.9, 
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55.2*, 70.2*, 71.4, 77.3, 79.2, 79.4*, 90.5*, 92.3, 156.4, 156.5*, 207.6. IR (νmax/cm
-1) 
3380 (m), 2959 (m), 1955 (m), 1683 (s), 1506 (s), 1365 (s), 1248 (s), 1166 (s), 1055 
(s), 1018 (s), 843 (s). HRMS (ESI-TOF) m/z calcd for C13H23NO3Na [M + Na]
+ 
264.1576, found 264.1573. 
 
(4S,5S)-5-(Propa-1,2-dien-1-yl)-4-propyloxazolidin-2-one (23b). The title 
compound 23b was obtained as s single diastereomer after column chromatography 
(acetone/n-pentane 2:8) following the general procedure A using 9b (0.067 g, 0.28 
mmol) and sodium hydride (60% in mineral oil, 18.81 mg, 0.56 mmol, 2.0 equiv.) in 
THF (1 mL). Colorless oil (0.026 g, 55%). Rf (acetone/n-pentane 2:8) = 0.45. 
	= 
−24.9 (c 1.3 CHCl3). 
1
H NMR (500 MHz, CDCl3) δ 0.95 (t, 3H, J = 7.0, 7.5 Hz, 
CH3), 1.32-1.43 (m, 2H, CH2), 1.54-1.57 (m, 2H, CH2), 3.67 (q, 1H, J = 6.5 Hz, CH), 
4.62-4.65 (m, 1H, CH), 4.96-4.99 (m, 2H, CH2=C=), 5.34 (q, 1H, J = 6.5, 7.0 Hz, 
CH=C=), 6.51 (br s, 1H, NH). 13C{1H} NMR (125 MHz, CDCl3) δ 73.7, 78.6, 96.7, 
117.8, 138.4, 140.0, 149.4, 219.0, 268.8. IR (νmax/cm
-1) 3266 (m), 2959 (m), 2932 
(m), 1955 (m), 1742 (s), 1387 (s), 1239 (s), 1239 (s), 978 (s), 852 (s), 767 (s). HRMS 
(ESI-TOF) m/z calcd for C9H12NO2 [M − H]
+ 166.0862, found 166.0870.  
 
tert-Butyl ((4S,5S)-5-hydroxy-2-methylocta-6,7-dien-4-yl)carbamate (9c). 
The title compound 9c was obtained after flash column chromatography 
(EtOAc/hexane 2:8) as a 5.7:1 mixture of syn and anti diastereomers following the 
general procedure A using tert-butyl (4-methyl-1-oxopentan-2-yl)carbamate 2c (0.18 
g, 0.83 mmol), allenylboronic acid pinacol ester 1 (176.56 µL, 0.92 mmol, 1.1 equiv.) 
and Et2Zn (1 M in toluene, 88.80 µL, 0.083 mmol, 10 mol%)  in dry toluene (2 mL). 




(500 MHz, CDCl3) (mixture of two allene diastereomers, relative integrations given 
for each diastereomer) δ 0.92 (d, 6H, J = 6.0 Hz, 2CH3, for each isomer), 1.27-1.39 
(m, 1H, CH, for each isomer), 1.43 (s, 9H, C(CH3)3, for each isomer), 1.65-1.68 (m, 
2H, CH2, for each isomer), 3.11 (br s, 1H, OH, major isomer), 2.95 (br s, 1H, OH, 
minor isomer), 3.68 (br s, 1H, CH, major isomer), 3.70-3.80 (br s, 1H, CH, minor 
isomer), 4.12 (br s, 1H, CH, major isomer), 4.22 (br s, 1H, CH, minor isomer), 4.79-
4.90 (m, 2H, CH2=C=, for each isomer), 5.18-5.20 (m, 1H, CH=C=, minor isomer), 
5.25-5.27 (m, 1H, CH=C=, major isomer). 13C{1H} NMR (125 MHz, CDCl3) 
(mixture of two allene diastereomers, minor indicated by asterisk) δ 22.0*, 23.2, 24.8, 
28.3, 40.8, 41.3*, 53.2, 53.9*, 71.7, 72.5*, 76.8, 79.2, 79.7*, 91.2*, 92.3, 156.3, 
156.5*, 207.6. IR (νmax/cm
-1) 3361 (m), 2956 (m), 1955 (m), 1682 (s), 1504 (s), 1365 
(s), 1248 (s), 1166 (s), 1047 (s), 843 (s). HRMS (ESI-TOF) m/z calcd for 
C14H25NO3Na [M + Na]
+ 278.1732, found 278.1720.  
(4S,5S)-4-Isobutyl-5-(propa-1,2-dien-1-yl)oxazolidin-2-one (23c). The title 
compound 23c was obtained as s single diastereomer after column chromatography 
(acetone/n-pentane 2:8) following the general procedure A using 9c (0.05 g, 0.195 
mmol) and sodium hydride (60% in mineral oil, 18.81 mg, 0.39 mmol, 2.0 equiv.) in 
THF (1 mL). Colorless oil (0.021 g, 58%). Rf (acetone/n-pentane 2:8) = 0.30. 
	= 
−32.6 (c 1 CHCl3). 
1
H NMR (500 MHz, CDCl3) δ 0.91-0.93 (m, 6H, 2CH3), 1.38-
1.43 (m, 1H, CH), 1.48-1.53 (m, 1H, CH), 1.61-1.68 (m, 1H, CH), 3.70-3.74 (m, 1H, 
CH), 4.58-4.61 (m, 1H, CH), 4.93-5.00 (m, 2H, CH2=C=), 5.33 (q, 1H, J = 6.5 Hz, 
CH=C=), 6.28 (br s, 1H, NH). 13C{1H} NMR (125 MHz, CDCl3) δ 22.2, 23.1, 25.2, 
44.1, 56.5, 78.6, 80.5, 89.5, 159.1, 209.1. IR (νmax/cm
-1) 3256 (m), 2962 (m), 1956 
(w), 1742 (s), 1387 (m), 1228 (m), 993 (m), 852 (m), 734 (m). HRMS (ESI-TOF) m/z 
calcd for C10H15NO2Na [M + Na]




(9d). The title compound 9d was obtained after flash column chromatography 
(EtOAc/hexane 2:8) as a 9:1 mixture of syn and anti diastereomers following the 
general procedure A using tert-butyl (3-methyl-1-oxobutan-2-yl)carbamate 2d (0.10 
g, 0.496 mmol), allenylboronic acid pinacol ester 1 (103.75 µL, 0.54 mmol, 1.1 
equiv.) and Et2Zn (1 M in toluene, 37.14 µL, 0.035 mmol, 7 mol%)  in dry toluene (1 
mL). White solid (0.106 g, 88%). Mp = 39-41 °C. Rf (EtOAc/hexane 2:8) = 0.35. 
1
H 
NMR (500 MHz, CDCl3) (mixture of two allene diastereomers, relative integrations 
given for each diastereomer) δ 0.94 (d, 3H, J = 6.5 Hz, CH3, for each isomer), 0.99 (d, 
3H, J = 6.5 Hz, CH3, for each isomer), 1.44 (s, 9H, C(CH3)3, for each isomer), 1.87-
1.93 (m, 1H, CH, for each isomer), 2.68 (br s, 1H, OH, minor isomer), 2.80 (br s, 1H, 
OH, major isomer), 3.20-3.23 (m, 1H, CH, minor isomer), 3.26-3.29 (m, 1H, CH, 
major isomer), 4.28 (br s, 1H, CH, minor isomer), 4.33 (br s, 1H, CH, major isomer), 
4.85-4.93 (m, 2H, CH2=C=, for each isomer), 5.19-5.21 (m, 1H, CH=C=, minor 
isomer), 5.25-5.26 (m, 1H, CH=C=, major isomer). 13C{1H} NMR (125 MHz, 
CDCl3) (mixture of two allene diastereomers, minor indicated by asterisk) δ 18.8, 
19.9, 20.1, 28.3, 29.8, 30.0*, 60.4, 60.8*, 69.3, 69.4*, 76.8, 79.1, 79.2*, 90.7*, 93.0, 
156.6, 156.7*, 207.4, 207.9*. IR (νmax/cm
-1) 3373 (m), 2979 (m), 2361 (m), 1955 (w), 
1662 (s), 1525 (s), 1367 (s), 1245 (s), 1166 (s), 1018 (m), 869 (m), 684 (m). HRMS 
(ESI-TOF) m/z calcd for C13H23NO3Na [M + Na]
+ 264.1576, found 264.1581.  
 
(4S,5S)-4-Isopropyl-5-(propa-1,2-dien-1-yl)oxazolidin-2-one (23d). The 
title compound 23d was obtained as a 4.3:1 mixture of two diastereomers after 
column chromatography (acetone/n-pentane 2:8) following the general procedure A 
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using 9d (0.10 g, 0.414 mmol) and sodium hydride (60% in mineral oil, 27.88 mg, 
0.83 mmol, 2.0 equiv.) in THF (1 mL). Milky oil (0.106 g, 74%). Rf (acetone/n-
pentane 2:8) = 0.44. 1H NMR (500 MHz, CDCl3) (mixture of two diastereomers, 
relative integrations given for each diastereomer) δ 0.94 (br d, 3H, J = 6.5 Hz, CH3, 
major isomer), 0.98 (br d, 3H, J = 6.0 Hz, CH3, major isomer), 0.99 (br d, 3H, J = 6.0 
Hz, CH3, minor isomer), 1.77 (br s, 1H, CH, major isomer), 1.90 (br s, 1H, CH, minor 
isomer), 3.45 (br s, 1H, CH, major isomer), 3.61-3.63 (m, 1H, CH, major isomer), 
4.74 (br s, 1H, CH, major isomer), 4.92-4.97 (m, 2H, CH2=C=, for each isomer), 
5.04-5.06 (m, 1H, CH, minor isomer), 5.32-5.37 (m, 1H, CH=C=, for each isomer), 
6.58 (br s, 1H, NH, minor isomer), 6.66 (br s, 1H, NH, major isomer). 13C{1H} NMR 
(125 MHz, CDCl3) (mixture of two diastereomers, minor indicated by asterisk) δ 
17.93, 17.97, 28.1*, 32.3, 62.3*, 63.5, 75.5*, 78.0, 78.6, 78.7*, 85.9*, 90.4, 159.1, 
159.8*, 208.7, 210.0*. IR (νmax/cm
-1) 3260 (m), 2963 (m), 1955 (w), 1743 (s), 1387 
(m), 1228 (m), 993 (m), 851 (m), 734 (m). HRMS (ESI-TOF) m/z calcd for 
C9H13NO2Na [M + Na]
+ 190.0838, found 190.0840.  
 
tert-Butyl ((2S,3S)-3-hydroxy-1-phenylhexa-4,5-dien-2-yl)carbamate (9e). 
The title compound 9e was obtained after flash column chromatography 
(EtOAc/hexane 3:7) as a 2.5:1 mixture of syn and anti diastereomers following the 
general procedure A using tert-butyl (1-oxo-3-phenylpropan-2-yl)carbamate 2e 
(0.093 g, 0.373 mmol), allenylboronic acid pinacol ester 1 (78.78 µL, 0.41 mmol, 1.1 
equiv.) and Et2Zn (1 M in toluene, 40.00 µL, 0.0373 mmol, 10 mol%)  in dry toluene 
(1 mL). White solid (0.087 g, 80%). Mp = 60-62 °C. Rf (EtOAc/hexane 3:7) = 0.53. 
1
H NMR (500 MHz, CDCl3) (mixture of two allene diastereomers, relative 
integrations given for each diastereomer) δ 1.36 (s, 9H, C(CH3)3, minor isomer), 1.43 
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(s, 9H, C(CH3)3, major isomer), 2.61 (br s, 1H, OH, major isomer), 2.88-2.96 (m, 2H, 
CH2Ph, for each isomer), 3.76 (br s, 1H, CH, minor isomer), 3.82 (br s, 1H, CH, 
major isomer), 4.15 (br s, 1H, CH, major isomer), 4.27 (br s, 1H, CH, minor isomer), 
4.85-4.91 (m, 2H, CH2=C=, for each isomer), 5.24-5.29 (m, 1H, CH=C=, for each 




H} NMR (125 MHz, 
CDCl3) (mixture of two allene diastereomers, minor indicated by asterisk) δ 28.5, 
36.1*, 38.2, 56.1*, 56.4, 69.4, 77.9*, 78.0, 79.4, 79.8*, 91.2*, 92.6, 126.3*, 126.6, 
128.4, 129.2*, 129.32*, 129.37, 138.0*, 138.2, 156.0, 207.4*, 207.6. IR (νmax/cm
-1) 
3379 (m), 2981 (w), 2358 (s), 1954 (w), 1675 (s), 1521 (s), 1452 (m), 1248 (s), 1168 
(s), 1002 (m), 837 (s), 759 (m), 703 (s). HRMS (ESI-TOF) m/z calcd for C17H24NO3 
[M + H]+ 290.1756, found 290.1751.   
 
(4S,5S)-4-Benzyl-5-(propa-1,2-dien-1-yl)oxazolidin-2-one (23e). The title 
compound 23e was obtained as a 3:1 mixture of two diastereomers after column 
chromatography (acetone/n-pentane 2:8) following the general procedure A using 9e 
(0.087 g, 0.30 mmol) and sodium hydride (60% in mineral oil, 20.16 mg, 0.60 mmol, 
2.0 equiv.) in THF (1 mL). Colorless oil (0.041 g, 63%). Rf (acetone/n-pentane 2:8) = 
0.31. 1H NMR (500 MHz, CDCl3) (mixture of two diastereomers, relative 
integrations given for each diastereomer) δ 2.70-2.75 (m, 2H, CH2Ph, minor isomer), 
2.86-2.90 (m, 2H, CH2Ph, major isomer), 3.90 (q, 1H, J = 6.5 Hz, CH, major isomer), 
4.10-4.14 (m, 1H, CH, minor isomer), 4.72 (t, 1H, J = 6.0 Hz, CH, major isomer), 
4.84-4.93 (m, 2H, CH2=C=, major isomer), 4.96-4.98 (m, 2H, CH2=C=, minor 
isomer), 5.13 (t, 1H, J = 8.0 Hz, CH, minor isomer), 5.24 (q, 1H, J = 6.5, 7.0 Hz, 
CH=C=, major isomer), 5.35 (q, 1H, J = 7.0 Hz, CH=C=, minor isomer), 5.65 (br s, 
1H, NH, minor isomer), 6.19 (br s, 1H, NH, major isomer), 7.16 (d, 2H, J = 7.5 Hz, 
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2CHAr, for each isomer), 7.22-7.25 (m, 1H, CHAr, for each isomer), 7.29-7.32 (m, 2H, 




H} NMR (125 MHz, CDCl3) (mixture of two 
diastereomers, minor indicated by asterisk) δ 37.5*, 40.9, 57.5*, 59.3, 78.0*, 78.3*, 
78.7, 79.3, 86.3*, 89.5, 127.33, 127.39*, 129.10, 129.18*, 129.2*, 129.4, 136.0, 
136.9*, 158.7, 209.0, 210.0*. IR (νmax/cm
-1) 3267 (w), 2917 (w), 1955 (w), 1743 (s), 
1386 (m), 1230 (m), 992 (s), 854 (s), 699 (s). HRMS (ESI-TOF) m/z calcd for 
C13H13NO2Na [M + Na]
+ 238.0838, found 238.0840. 
 
tert-Butyl 3-((2S,3S)-2-((tert-butoxycarbonyl)amino)-3-hydroxyhexa-4,5-
dien-1-yl)-1H-indole-1-carboxylate (9f). The title compound 9f was obtained after 
flash column chromatography (EtOAc/hexane 2:8) as a 2.5:1 mixture of syn and anti 
diastereomers following the general procedure A using tert-butyl 3-(2-((tert-
butoxycarbonyl)amino)-3-oxopropyl)-1H-indole-1-carboxylate 2f (0.05 g, 0.128 
mmol), allenylboronic acid pinacol ester 1 (27.00 µL, 0.14 mmol, 1.1 equiv.) and 
Et2Zn (1 M in toluene, 14.00 µL, 0.0128 mmol, 10 mol%)  in dry toluene (1 mL). 
Colorless oil (0.043 g, 78%). Rf (EtOAc/hexane 2:8) = 0.33. 
1
H NMR (500 MHz, 
CDCl3) (mixture of two allene diastereomers, relative integrations given for each 
diastereomer) δ 1.39 (s, 9H, C(CH3)3, minor isomer), 1.42 (s, 9H, C(CH3)3, major 
isomer), 1.65 (s, 9H, C(CH3)3, for each isomer), 2.52 (br s, 1H, OH, major isomer), 
2.91-3.06 (m, 2H, CH2, for each isomer), 3.93 (br s, 1H, CH, major isomer), 4.06 (br 
s, 1H, CH, minor isomer), 4.23 (br s, 1H, CH, major isomer), 4.32 (br s, 1H, CH, 
minor isomer),  4.87-5.04 (m, 2H, CH2=C=, for each isomer), 5.26-5.32 (m, 1H, 
CH=C=, for each isomer), 7.22-7.66 (m, 4H, 4CHAr, for each isomer), 8.13 (br s, 1H, 




H} NMR (125 MHz, CDCl3) (mixture of two allene 
diastereomers, minor indicated by asterisk) δ 28.2, 28.3*, 54.7, 55.3*, 69.3, 71.7*, 
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78.1*, 78.3, 79.5, 79.8*, 83.5, 91.3*, 92.6, 115.21, 115.27*, 116.8*, 117.0, 119.0, 
119.2*, 122.5, 123.9, 124.41, 124.46*, 130.7, 135.4, 149.7, 156.1, 207.4, 207.5*. IR 
(νmax/cm
-1) 3385 (w), 2975 (w), 2930 (w), 1955 (w), 1730 (s), 1684 (s), 1507 (m), 
1452 (s), 1367 (s), 1252 (s), 1157 (s), 1085 (s), 1015 (m), 852 (m), 744 (s). HRMS 
(ESI-TOF) m/z calcd for C24H32N2O5Na [M + Na]
+ 451.2209, found 451.2227. 
 
tert-Butyl 3-(((4R,5R)-2-oxo-5-(propa-1,2-dien-1-yl)oxazolidin-4-
yl)methyl)-1H-indole-1-carboxylate (23f). The title compound 23f was obtained as a 
single diastereomer after careful column chromatography (acetone/n-pentane 2:8) 
following the general procedure A using 9f (0.036 g, 0.084 mmol) and sodium 
hydride (60% in mineral oil, 5.68 mg, 0.168 mmol, 2.0 equiv.) in THF (1 mL). 
Colorless gummy oil (0.015 g, 50%). Rf (acetone/n-pentane 2:8) = 0.26. 
	= 
−35.8 (c 0.7 CHCl3). 
1
H NMR (500 MHz, CDCl3) δ 1.68 (s, 9H, C(CH3)3), 2.90-2.94 
(m, 1H, CH), 3.00-3.04 (m, 1H, CH), 4.03 (br s, 1H, CH), 4.81 (br s, 1H, CH), 4.96 
(br s, 2H, CH2=C=),  5.19 (br s, 1H, NH), 5.37 (br d, 1H, J = 6.5 Hz, CH=C=), 7.26 





H} NMR (125 MHz, CDCl3) δ 28.2, 30.5, 57.5, 78.8, 79.4, 84.0, 89.2, 
114.9, 115.5, 118.5, 122.8, 123.9, 124.9, 129.7, 135.6, 149.4, 157.7, 208.8. IR 
(νmax/cm
-1) 3277 (w), 2982 (w), 2357 (w), 1955 (w), 1751 (s), 1730 (s), 1452 (s), 1368 
(s), 1255 (s), 1155 (s), 1086 (m), 854 (m). HRMS (ESI-TOF) m/z calcd for 
C20H23N2O4 [M + H]
+ 355.1658, found 355.1664. 
 
(2S,3S)-2-(Tritylamino)hexa-4,5-dien-3-ol (12). The title compound 12 was 
obtained after flash column chromatography (Et2O/hexane 2:8) as a 1.3:1 mixture of 
syn and anti diastereomers following the general procedure A using 2-
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(tritylamino)propanal 5 (0.10 g, 0.317 mmol), allenylboronic acid pinacol ester 1 
(78.00 µL, 0.41 mmol, 1.1 equiv.) and Et2Zn (1 M in toluene, 34.0 µL, 0.0317 mmol, 
10 mol%)  in dry toluene (1 mL). Colorless oil (0.093 g, 82%). Rf (Et2O/hexane 2:8) 
= 0.41. 1H NMR (300 MHz, CDCl3) (mixture of two allene diastereomers, relative 
integrations given for each diastereomer) δ 0.43 (d, 3H, J = 6.0 Hz, CH3, minor 
isomer), 0.75 (d, 3H, J = 6.6 Hz, CH3, major isomer), 2.23 (br s, 1H, NH, for each 
isomer), 2.69-2.77 (m, 1H, CH, for each isomer), 3.40-3.43 (m, 1H, CH, for each 
isomer), 4.74-4.77 (m, 2H, CH2=C, major isomer), 4.80-4.83 (m, 2H, CH2=C, minor 
isomer), 4.98 (q, 1H, J = 6.0, 6.3 Hz, CH=C, major isomer), 5.22 (q, 1H, J = 6.6, 6.6 
Hz, CH=C, minor isomer), 7.15-7.28 (m, 10H, 10CHAr, for each isomer), 7.54 (d, 5H, 




H} NMR (75 MHz, CDCl3) (mixture of 
two allene diastereomers, minor indicated by asterisk) δ 15.9, 17.1*, 52.6, 53.0*, 
71.2, 71.3*, 73.2*, 76.6, 91.7*, 92.2, 126.4, 127.9, 128.7, 128.8*, 146.73, 146.76*, 
207.1, 207.9*. IR (νmax/cm
-1) 3385 (w), 3056 (w), 2970 (w), 1952 (m), 1490 (s), 1447 
(s), 1031 (s), 845 (s), 744 (s), 705 (s). HRMS (ESI-TOF) m/z calcd for C25H26NO [M 
+ H]+ 356.2014, found 356.2011. 
 
General Procedure B. Allenylation of Chiral N,N-[((tert-butoxy)carbonyl)benzyl] 
amino aldehydes and Subsequent Gold-Catalyzed Cyclization. To a solution of 
allenylboronic acid pinacol ester 1 (1.3 equiv.) and the amino aldehydes 6a-g in 
toluene at 0 °C, was added Et2Zn (1 M in toluene, 10 mol%) under nitrogen. The 
suspension was then stirred at 0 °C for 18 h. The reaction mixture was quenched with 
saturated aqueous NH4Cl solution (5 mL), and then washed with saturated aqueous 
NaHCO3 solution (15 mL) and water (10 mL). The organic layer was dried (Na2SO4), 
and then concentrated under reduced pressure to afford the resulting allenyl amino 
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alcohol product 13. Then, to a solution of this crude product in dry dichloroethane 
was added AuPPh3NTf2 (10 mol%). The reaction was stirred at 60 °C for 8 h and then 
filtered through a pad of silica gel and after removal of the solvent the crude product 
was used in the next step without purification. Chlorotrimethylsilane (5 equiv.) was 
added to a solution of the crude dihydrofuran in dry methanol. The reaction mixture 
was stirred at room temperature overnight, and then was neutralized by the addition of 
saturated aqueous NaHCO3 solution to about pH = 7, followed by purification by flash 
column chromatography to afford the corresponding Boc-deprotected dihydrofuran 
products 25a-25g. 
 
tert-Butyl benzyl((2S,3R)-3-hydroxyhexa-4,5-dien-2-yl)carbamate (13). 
The title compound 13 was prepared following the first part of general procedure B 
(in this case was purified by column chromatography as part of the optimization 
study) using tert-butyl benzyl(1-oxopropan-2-yl)carbamate 6a (0.065 g, 0.24 mmol), 
allenylboronic acid pinacol ester 1 (61 µL, 0.32 mmol, 1.3 equiv.) and Et2Zn (1 M in 
toluene, 25 µL, 0.024 mmol, 10 mol%)  in dry toluene (2 mL). The crude product was 
purified by flash column chromatography (EtOAc/hexane 2:8) as a 19:1 mixture of 
anti and syn diastereomers. Colorless oil (0.07 g, 96%). Rf (EtOAc/hexane 2:8) = 
0.31. 
= +7.31 (c 7.2 CH3Cl). 
1
H NMR (500 MHz, CDCl3) (mixture of rotamers) 
δ 1.17 (d, 0.7H, J = 7.0 Hz), 1.20 (d, 2.3H, J = 7.0 Hz), 1.33-1.45 (br s, 9H, C(CH3)3), 
3.70-3.76 (m, 1H, CH), 4.01-4.12 (m, 0.7H), 4.35-4.49 (m, 3.3H), 4.80 (m, 2H, 





(125 MHz, CDCl3) (mixture of rotamers, minor rotamer indicated by asterisk) δ 11.9, 
28.3, 51.1, 58.5*, 58.7, 72.9, 77.4, 80.6, 80.6*, 92.8, 127.0, 127.1, 127.3*, 128.4, 
128.5*, 139.1, 156.7, 207.1. IR (νmax/cm
-1) 3473 (m), 2976 (m), 1956 (m), 1680 (s), 
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1452 (s), 1365 (s), 1332 (m), 1250 (m), 1164 (s), 1012 (s), 860 (s), 699 (s). HRMS 
(ESI-TOF) m/z calcd for C18H25NO3Na [M + Na]
+ 326.1721, found 326.1731.  
 
N-Benzyl-N-((2S,3R)-3-hydroxyhexa-4,5-dien-2-yl)-4-
methylbenzenesulfonamide (14). The major diastereomer of the title compound 14 
was obtained after purification by flash column chromatography (EtOAc/hexane 3:7) 
following the first pat of general procedure B using N-benzyl-4-methyl-N-(1-
oxopropan-2-yl)benzenesulfonamide 7 (0.072 g, 0.226 mmol), allenylboronic acid 
pinacol ester 1 (56.50 µL, 0.29 mmol, 1.3 equiv.) and Et2Zn (1 M in toluene, 24.00 
µL, 0.0226 mmol, 10 mol%)  in dry toluene (1 mL). Colorless oil (0.044 g, 54%). Rf 
(EtOAc/hexane 3:7) = 0.44. 
	= +35.2 (c 2.5 CHCl3). 
1
H NMR (500 MHz, 
CDCl3) δ 1.01 (d, 3H, J = 7.0 Hz, CH3), 1.84 (d, 1H, J = 4.0 Hz, OH), 2.42 (s, 3H, 
CH3), 3.88-3.91 (m, 1H, CH), 4.03 (br s, 1H, CH), 4.27 (d, 1H, J = 15.5 Hz, CHPh), 
4.60 (d, 1H, J = 16.0 Hz, CHPh), 4.78-4.80 (m, 2H, CH2=C=), 5.15 (q, 1H, J = 6.5, 
6.5 Hz, CH=C=), 7.23-7.31 (m, 5H, 5CHAr), 7.37 (d, 2H, J = 7.5 Hz, 2CHAr), 7.69 (d, 




H} NMR (125 MHz, CDCl3) δ 12.4, 21.5, 48.5, 58.6, 
71.8, 78.3, 93.0, 127.1, 127.5, 128.2, 128.5, 129.7, 137.7, 137.9, 143.3, 207.0. IR 
(νmax/cm
-1) 3502 (m), 2984 (w), 2922 (w), 1954 (m), 1598 (m), 1333 (s), 1150 (s), 
1088 (s), 1002 (s), 863 (S), 732 (s), 657 (s). HRMS (ESI-TOF) m/z calcd for 
C20H23NO3NaS [M + Na]
+ 380.1296, found 380.1285. 
 
(2S,3R)-2-(Dibenzylamino)hexa-4,5-dien-3-ol (15). The major diastereomer 
of the title compound 15 was obtained after purification by flash column 
chromatography (Et2O/hexane 1:9) following the general procedure B using 2-
(dibenzylamino)propanal 8 (0.096 g, 0.339 mmol), allenylboronic acid pinacol ester 1 
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(84.00 µL, 0.44 mmol, 1.3 equiv.) and Et2Zn (1 M in toluene, 36.00 µL, 0.0339 mmol, 
10 mol%) in dry toluene (1 mL). Colorless oil (0.05 g, 50%). Rf (Et2O/hexane 1:9) = 
0.25. 
	= -36.2 (c 4.1 CHCl3). 
1
H NMR (500 MHz, CDCl3) δ 1.12 (d, 3H, J = 
11.5 Hz, CH3), 2.85-2.89 (m, 1H, CH), 3.42 (d, 2H, J = 23.0 Hz, 2CHPh), 3.82 (d, 
2H, J = 23.0 Hz, 2CHPh), 4.07-4.12 (m, 1H, CH), 4.77-4.81 (m, 2H, CH2=C=), 5.30 




H} NMR (125 
MHz, CDCl3) δ 9.2, 54.9, 57.7, 71.1, 76.8, 93.6, 127.2, 128.5, 129.0, 139.9, 207.6. IR 
(νmax/cm
-1) 3379 (w), 3027 (w), 2926 (w), 2801 (w), 1952 (m), 1452 (m), 1368 (m), 
1244 (w), 1027 (s), 845 (s), 744 (s), 696 (s). HRMS (ESI-TOF) m/z calcd for 
C20H24NO [M + H]
+ 294.1858, found 294.1852. 
 
(4S,5R)-3-Benzyl-4-methyl-5-(propa-1,2-dien-1-yl)oxazolidin-2-one  (24). 
To a solution of the allenyl product 13 (0.09 g, 0.29 mmol) in dry THF (1 mL) was 
added sodium hydride (60% in mineral oil, 16.00 mg, 0.59 mmol, 2.0 equiv.) at 0 °C. 
The reaction was stirred at room temperature for 60 min. Then, the reaction mixture 
was quenched with saturated aqueous NH4Cl solution (5 mL), washed with water (10 
mL) and dried (MgSO4). Purification by flash column chromatography 
(EtOAc/hexane 3:7) afforded the corresponding oxazolidinone product 24. Light 
yellow oil (0.035 g, 52%). Rf (EtOAc/hexane 3:7) = 0.40. 
	= −56.7 (c 1.7 
CHCl3). 
1
H NMR (300 MHz, CDCl3) δ 1.14 (d, 3H, J = 6.6 Hz, CH3), 3.69-3.78 (m, 
1h, CH), 4.03 (d, 1H, J = 15.3 Hz, CHPh), 4.82 (d, 1H, J = 15.0 Hz, CHPh), 4.86-4.98 




H} NMR (75 MHz, CDCl3) δ 13.7, 45.7, 53.3, 76.1, 77.6, 86.1, 127.9, 128.0, 
128.8, 135.9, 157.5, 209.7. IR (νmax/cm
-1) 2924 (w), 2358 (w), 1358 (w), 1743 (s), 
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1675 (m), 1414 (s), 1243 (m), 1159 (m), 761 (m), 700 (s). HRMS (ESI-TOF) m/z 
calcd for C14H15NO2Na [M + Na]
+ 252.1000, found 252.1003. 
 
(S)-N-benzyl-1-((R)-2,5-dihydrofuran-2-yl)ethan-1-amine (25a). Following 
the general procedure B using 0.065 g, 0.24 mmol of 6a, the resulting crude of 13 was 
treated with AuPPh3NTf2 (17.50 mg, 0.024 mmol, 10 mol%), followed by Boc-
deprotection of the crude product by treatment with chlorotrimethylsilane (0.14 mL, 
1.20 mmol, 5 equiv.) in methanol (2 mL). The title compound 25a was obtained as a 
single diastereomer after purification by flash column chromatography (Et2O/hexane 
7:3). The isolated yield was calculated for the three steps starting from the aldehyde 
6a. Colorless oil (0.03 g, 60%). Rf (Et2O/hexane 7:3) = 0.15. The ee was determined 
by chiral HPLC of the corresponding alcohol using a Phenomenex Lux Cellulose-3 
column; hexane/isopropanol (98:2); flow rate = 0.5 mL/min; 210 nm; tmajor = 9.83 
min, tminor = 10.95 min, 91% ee. 
	= +104.5 (c 0.9 CHCl3). 
1
H NMR (500 MHz, 
CDCl3) δ 1.06 (d, 3H, J = 6.5 Hz, CH3), 1.69 (s, 1H, NH), 2.85-2.88 (m, 1H, CH), 
3.79 (d, 1H, J = 13.5 Hz, CHPh), 3.90 (d, 1H, J = 13.5 Hz, CHPh), 4.62-4.69 (m, 2H, 
CH2), 4.87-4.88 (m, 1H, CH), 5.81-5.82 (m, 1H, CH), 5.95-5.97 (m, 1H, CH), 7.21-




H} NMR (125 MHz, CDCl3) δ 15.6, 51.4, 55.5, 75.7, 89.4, 
126.8, 127.0, 127.7, 128.0, 128.3, 140.7. IR (νmax/cm
-1) 3327 (w), 3026 (w), 2964 
(w), 2845 (m), 1683 (m), 1630 (m), 1494 (m), 1452 (m), 1355 (m), 1269 (m), 1068 
(s), 1028 (s), 950 (s), 847 (m), 731 (s), 696 (s). HRMS (ESI-TOF) m/z calcd for 
C13H18NO [M + H]
+ 204.1388, found 204.1393. 
 
(S)-N-benzyl-1-((R)-2,5-dihydrofuran-2-yl)butan-1-amine (25b). The 
allenyl precursor was prepared following B the general procedure using tert-butyl 
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benzyl(1-oxopentan-2-yl)carbamate 6b (0.485 g, 1.66 mmol), allenylboronic acid 
pinacol ester 1 (0.41 mL, 2.16 mmol, 1.3 equiv.) and Et2Zn (1M in toluene, 180 µL, 
0.048 mmol, 10 mol%)  in dry toluene (5 mL). Following the general procedure B the 
crude allenyl product was treated with AuPPh3NTf2 (0.117 g, 0.16 mmol, 10 mol%) 
in dry dichloroethane (5 mL). Boc-deprotection of the resulting dihydrofuran with 
chlorotrimethylsilane (0.95 mL, 8.00 mmol, 5 equiv.) in methanol (5 mL) gave the 
title compound 25b as a 4.3:1 mixture of syn and anti diastereomers after purification 
by flash column chromatography (Et2O/hexane 2:8). The isolated yield was calculated 
for the three steps starting from the aldehyde 6b. Colorless oil (0.26 g, 68%), Rf 
(Et2O/hexane 2:8) = 0.30. 
1
H NMR (300 MHz, CDCl3) (mixture of two 
diastereomers, relative integrations given for each diastereomer) δ 0.88 (t, 3H, J = 
6.30, 6.9 Hz, CH3, for each isomer), 1.28-1.49 (br m, 2H, CH2, for each isomer), 2.50-
2.60 (m, 1H, CH, minor isomer), 2.69 (q, 1H, J = 8.5, 10.5 Hz, CH, major isomer), 
3.80 (s, 2H, CH2Ph, minor isomer), 3.83 (s, 2H, CH2Ph, major isomer), 4.58-4.70 (m, 
2H, CH2, for each isomer), 4.84-4.86 (m, 1H, CH, minor isomer), 4.93-4.94 (m, 1H, 
CH, major isomer), 5.81-5.83 (m, 1H, CH=, for each isomer), 5.90-5.96 (m, 1H, CH=, 




H} NMR (75 
MHz, CDCl3) (mixture of two diastereomers, minor indicated by asterisk) δ 14.3, 
14.4*, 19.3*, 19.5, 33.1*, 33.3, 51.8*, 52.3, 60.2, 60.3*, 75.3*, 75.4, 88.3*, 88.6, 
126.7, 127.2, 127.4*, 127.7, 127.8, 128.0*, 128.2, 140.9. IR (νmax/cm
-1) 3735 (w), 
2956 (m), 2871 (m), 2844 (m), 1457 (m), 1354 (w), 1073 (s), 734 (s), 696 (s). HRMS 
(ESI-TOF) m/z calcd for C15H21NONa [M + Na]
+ 254.1521, found 254.1531.   
 
(S)-N-benzyl-1-((R)-2,5-dihydrofuran-2-yl)-3-methylbutan-1-amine (25c). 
The allenyl precursor was prepared following B the general procedure using tert-butyl 
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benzyl(4-methyl-1-oxopentan-2-yl)carbamate 6c (0.198 g, 0.65 mmol), allenylboronic 
acid pinacol ester 1 (160 µL, 0.84 mmol, 1.3 equiv.) and Et2Zn (1 M in toluene, 70 
µL, 0.065 mmol, 10 mol%)  in dry toluene (2 mL).  Following the general procedure 
B the crude allenyl product was treated with AuPPh3NTf2 (44.90 mg, 0.06 mmol, 10 
mol%) in dry dichloroethane (2 mL). Boc-deprotection of the resulting dihydrofuran 
with chlorotrimethylsilane (0.38 mL, 3.25 mmol, 5 equiv.) in methanol (3 mL) gave 
the title compound 25c as a 3.2:1 mixture of syn and anti diastereomers after 
purification by flash column chromatography (Et2O/hexane 2:8). The isolated yield 
was calculated for the three steps starting from the aldehyde 6c. Colorless oil (0.097 
g, 62%), Rf (Et2O/hexane 2:8) = 0.36. 
1
H NMR (300 MHz, CDCl3) (mixture of two 
diastereomers, relative integrations given for each diastereomer) δ 0.81-0.92 (m, 6H, 
2CH3, for each isomer), 1.22-1.33 (m, 1H, CH, for each isomer), 1.74-2.00 (m, 1H, 
CH, for each isomer), 2.77-2.81 (m, 1H, CH, major isomer), 2.85-2.89 (m, 1H, CH, 
minor isomer), 3.28 (s, 1H, NH, minor isomer), 3.34 (s, 1H, NH, major isomer), 3.82-
3.92 (m, 2H, CH2Ph, for each isomer), 4.65-4.69 (m, 2H, CH2O, for each isomer), 
4.97-5.00 (m, 1H, CH, for each isomer), 5.80-5.82 (m, 1H, CH=, for each isomer), 




H} NMR (75 MHz, CDCl3) (mixture of two diastereomers, minor indicated by 
asterisk) δ 22.3, 23.5, 24.9, 40.4, 52.3, 54.0*, 58.2, 75.5, 88.8, 127.1, 126.8, 127.9*, 
128.2, 128.33*, 128.36, 140.9. IR (νmax/cm
-1) 3735 (w), 2956 (m), 2926 (m), 2868 
(m), 1457 (m), 1131 (m), 1074 (m), 740 (m), 697 (m), 619 (m). HRMS (ESI-TOF) 
m/z calcd for C16H24NO [M + H]
+ 246.1858, found 246.1854. 
 
(S)-N-benzyl-1-((R)-2,5-dihydrofuran-2-yl)-2-methylpropan-1-amine 
(25d). The allenyl precursor was prepared following the general procedure B using 
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tert-butyl benzyl(3-methyl-1-oxobutan-2-yl)carbamate 6d (0.53 g, 1.84 mmol), 
allenylboronic acid pinacol ester 1 (454 µL, 2.40 mmol, 1.3 equiv.) and Et2Zn (1 M in 
toluene, 197 µL, 0.184 mmol, 10 mol%)  in dry toluene (5 mL). Following the general 
procedure B the crude allenyl product was treated with AuPPh3NTf2 (0.13 g, 0.18 
mmol, 10 mol%) in dry dichloroethane (5 mL). Boc-deprotection of the resulting 
dihydrofuran with chlorotrimethylsilane (1.12 mL, 9.20 mmol, 5 equiv.) in methanol 
(5 mL) gave the title compound 25d as a single diastereomer after purification by 
flash column chromatography (Et2O/hexane 2:8). The isolated yield was calculated 
for the three steps starting from the aldehyde 6d. Colorless oil (0.263 g, 61%). Rf 
(Et2O/hexane 2:8) = 0.22. 
	= -43.3 (c 0.65 CHCl3). 
1
H NMR (500 MHz, CDCl3) 
δ 0.98 (d, 6H, J = 6.5 Hz, 2CH3), 1.84-1.87 (br m, 2H, CH, NH), 2.37 (br d, 1H, J = 
3.0 Hz, CH), 3.83 (dd, 2H, J = 13.0, 12.5 Hz, CH2Ph), 4.64 (br d, 2H, J = 13.0 Hz, 





H} NMR (125 MHz, CDCl3) δ 19.28, 20.2, 30.7, 53.9, 65.7, 75.6, 
87.9, 126.9, 127.2, 128.4, 129.2, 141.5. IR (νmax/cm
-1) 2955 (m), 2872 (m), 2359 (w), 
1457 (m), 1070 (s), 1028 (s), 739 (s), 697 (s). HRMS (ESI-TOF) m/z calcd for 
C15H22NO [M + H]
+ 232.1701, found 232.1703. 
 
(S)-N-benzyl-1-((R)-2,5-dihydrofuran-2-yl)-2-phenylethan-1-amine (25e). 
The allenyl precursor was prepared following the general procedure B using tert-butyl 
benzyl(1-oxo-3-phenylpropan-2-yl)carbamate 6e (0.278 g, 0.82 mmol), 
allenylboronic acid pinacol ester 1 (0.20 mL, 1.06 mmol, 1.3 equiv.) and Et2Zn (1 M 
in toluene, 85.00 µL, 0.082 mmol, 10 mol%)  in dry toluene (2 mL). Following the 
general procedure B the crude allenyl product was treated with AuPPh3NTf2 (60.00 
mg, 0.08 mmol, 10 mol%) in dry dichloroethane (3 mL). Boc-deprotection of the 
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resulting dihydrofuran with chlorotrimethylsilane (0.52 mL, 4.10 mmol, 5 equiv.) in 
methanol (3 mL) gave the title compound 25e as a 8.3:1 mixture of syn and anti 
diastereomers after purification by flash column chromatography (EtOAc/hexane 
3:7). The isolated yield was calculated for the three steps starting from the aldehyde 
6e. Light yellow oil (0.133 g, 58%). Rf (EtOAc/hexane 3:7) = 0.34. 
1
H NMR (500 
MHz, CDCl3) (mixture of two diastereomers, relative integrations given for each 
diastereomer) δ 2.70-2.74 (m, 1H, CHPh, for each isomer), 2.80-2.83 (m, 1H, CHPh, 
for each isomer), 2.90 (s, 1H, CH, minor isomer), 2.98 (br s, 1H, CH, major isomer), 
3.77 (q, 2H, J = 13.5 Hz, CH2Ph, for each isomer), 4.63-4.73 (m, 2H, 2CH−O, for 
each isomer), 4.89 (br s, 1H, CH, for each isomer), 5.78 (br s, 1H, CH=, minor 
isomer), 5.89 (br s, 1H, CH=, major isomer), 5.98 (br s, 1H, CH=, for each isomer), 




H} NMR (125 MHz, CDCl3) 
(mixture of two diastereomers, minor indicated by asterisk) δ 37.1, 37.4*, 52.10, 
52.16*, 61.80, 61.85*, 75.5*, 75.6, 87.8*, 88.0, 126.1*, 126.2, 126.7, 127.2, 127.73*, 
127.79*, 128.0, 128.3, 128.4, 129.3, 139.2, 139.5*, 140.5. IR (νmax/cm
-1) 3333 (w), 
3026 (w), 2844 (m), 1494 (m), 1452 (m), 1070 (s), 739 (s), 696 (s). HRMS (ESI-
TOF) m/z calcd for C19H22NO [M + H]
+ 280.1695, found 280.1697. 
 
tert-Butyl 3-((S)-2-(benzylamino)-2-((R)-2,5-dihydrofuran-2-yl)ethyl)-1H-
indole-1-carboxylate (25f). The allenyl precursor was prepared following the general 
procedure B using tert-butyl 3-(2-(benzyl(tert-butoxycarbonyl)amino)-3-oxopropyl)-
1H-indole-1-carboxylate 6f (0.389 g, 0.81 mmol), allenylboronic acid pinacol ester 1 
(0.20 mL, 1.05 mmol, 1.3 equiv.) and Et2Zn (1 M in toluene, 87.30 µL, 0.081 mmol, 
10 mol%)  in dry toluene (3 mL). Following the general procedure B the crude allenyl 
product was treated with AuPPh3NTf2 (59.15 mg, 0.08 mmol, 10 mol%) in dry 
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dichloroethane (4 mL). Boc-deprotection of the resulting dihydrofuran with 
chlorotrimethylsilane (0.52 mL, 4.05 mmol, 5 equiv.) in methanol (5 mL) gave the 
title compound 25f as a single diastereomer after purification by flash column 
chromatography (EtOAc/hexane 3:7). The isolated yield was calculated for the three 
steps starting from the aldehyde 6g. Light yellow oil (0.163 g, 48%). Rf 
(EtOAc/hexane 3:7) = 0.33. 
	= +39.3 (c 1.3 CHCl3). 
1
H NMR (300 MHz, 
CDCl3) δ 1.66 (br s, 9H, C(CH3)3), 2.76-2.92 (m, 2H, CH2), 3.07-3.13 (m, 1H, CH), 
3.81 (dd, 2H, J = 13.2, 13.5 Hz, CH2Ph), 4.63-4.78 (m, 2H, CH2), 4.95 (br s, 1H, CH), 
5.93 (br dd, 1H, J = 1.2, 0.9 Hz, CH), 6.01 (d, 1H, J = 6.3 Hz, CH), 7.16-7.21 (br m, 
5H, 5CHAr), 7.25-7.32 (m, 2H, 2CHAr), 7.44 (t, 2H, J = 12.6, 7.8 Hz, 2CHAr), 8.12 (br 




H} NMR (75 MHz, CDCl3) δ 26.3, 28.2, 52.1, 60.0, 
75.6, 83.3, 88.1, 115.2, 117.7, 119.1, 122.3, 123.6, 124.3, 126.7, 127.2, 127.9, 128.0, 
128.2, 130.7, 135.5, 140.3, 149.6. IR (νmax/cm
-1) 3670 (w), 2978 (w), 2842 (w), 1729 
(s), 1451 (s), 1367 (s), 1255 (s), 1155 (s), 1072 (s), 1015 (m), 935 (m), 856 (m), 743 
(s), 697 (s). HRMS (ESI-TOF) m/z calcd for C26H31N2O3 [M + H]




(25g). The allenyl precursor was prepared following the general procedure B using 
tert-butyl 2-formylpyrrolidine-1-carboxylate 6g (0.29 g, 1.45 mmol), allenylboronic 
acid pinacol ester 1 (0.36 mL, 1.89 mmol, 1.3 equiv.) and Et2Zn (1 M in toluene, 
156.3 µL, 0.145 mmol, 10 mol%) in dry toluene (3 mL). Following the general 
procedure B the crude allenyl product was treated with AuPPh3NTf2 (107.4 mg, 0.145 
mmol, 10 mol%) in dry dichloroethane (3 mL). The title compound 25g was obtained 
as a 1.6:1 mixture of syn and anti diastereomers after purification by flash column 
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chromatography (Et2O/hexane 3:7). The isolated yield was calculated for the two 
steps starting from the aldehyde 6g. Colorless oil (0.21 g, 59%), Rf (Et2O/hexane 3:7) 
= 0.18. 1H NMR (500 MHz, DMSO, 80 °C) (mixture of two diastereomers, relative 
integrations given for each diastereomer) δ 1.41 (s, 9H, C(CH3)3, for each isomer), 
1.70 (br s, 2H, 2CH2, major isomer), 1.80-1.85 (m, 4H, 2CH2, minor isomer) 3.14-
3.22 (m, 2H, CH2, major isomer), 3.31 (br s, 2H, CH2, minor isomer), 3.75 (s, 1H, 
CH, major isomer), 3.90 (s, 1H, CH, minor isomer),  4.47-4.54 (m, 2H, CH2, for each 
isomer), 4.97 (br s, 1H  CH, for each isomer), 5.79-5.81 (m, 1H, CH=, for each 
isomer), 6.02 (br s, 1H, CH=, for each isomer). 13C{1H} NMR (125 MHz, DMSO, 80 
°C) (mixture of two diastereomers, minor indicated by asterisk) δ  23.9, 25.7, 28.61, 
28.66*, 46.9*, 47.1, 59.7*, 60.6, 75.6, 78.7, 78.8*, 87.4, 127.2*, 128.0, 128.3, 128.4*, 
154.0, 154.3*. IR (νmax/cm
-1) 2972 (m), 2878 (m), 2845 (m), 2355 (w), 1687 (s), 1456 
(m), 1388 (s), 1363 (s), 1255 (m), 1165 (s), 1109 (s), 1072 (s), 769 (m), 678 (m). 
HRMS (ESI-TOF) m/z calcd for C13H21NO3Na [M + Na]
+ 262.1419, found 262.1427. 
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